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ABSTRACT 
 
Nodal signaling is one of the principal players in the process of 
gastrulation, during which the primary germ layers (endoderm, mesoderm, and 
ectoderm) are formed and organized in their proper locations. During my PhD I 
studied how Smad2 and FoxH1 transcription factors regulate the expression of Nodal 
target genes, and the relationship between the chromatin state of target genes and their 
expression. 
In order to carry out in depth analysis of FoxH1 function I generated a 
complete mutant of this transcription factor and used deep sequencing to identify 
which genes FoxH1 regulates in zebrafish development. Using ChIP-Seq 
experiments, I also found the binding sites of FoxH1 and found that FoxH1 is capable 
of binding to genomic DNA in the absence of Nodal signaling. This finding suggests 
that it may act as a pioneer factor, preparing target genes for rapid activation when 
gastrulation starts. I also identified 54 direct FoxH1 target genes that are not Nodal-
dependent, as well as 13 genes that are repressed, rather than activated, by FoxH1.  
To identify Smad2 binding sites, I carried out ChIP-Seq in embryos 
overexpressing Nodal signal Squint, thus detecting loci that bind Smad2 after 
exposure to high Nodal levels. I tested the identified Smad2-bound DNA elements for 
their gene regulatory potential, and discovered that they are sufficient to drive gene 
expression in a Nodal-dependent manner. I also identified 26 previously unpublished 
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Nodal target genes, and 55 genes that are bound by Smad2 upon exposure to high, but 
not low levels of Nodal signaling.  
In the last chapter I describe the study of the interaction between Nodal 
signaling in early zebrafish development and chromatin marks. I found that exposure 
of embryonic cells to high levels of Nodal is associated with low levels of H3K27me3 
and high levels of H3K4me3 marks on Nodal target genes, compared to unexposed 
cells. I also describe a Cas9-based system that we used to change H3K27me3 levels in 
a targeted manner, and tested it in a developing embryo on a Nodal-responsive fgf8a 
gene. Our results suggest that reduction of H3K27me3 mark on its own is not 
sufficient to affect the expression of this gene, and additional mechanisms are 
involved in target gene activation by Smad2.  
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Dedication 
 
To my family
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CHAPTER I 
INTRODUCTION 
It is not birth, marriage, or death, but gastrulation,  
which is truly the most important time in your life. 
            Lewis Wolpert (1986) 
 
Embryonic development starts with the fertilization of the egg, 
formation of a pluripotent cell population, and their subsequent differentiation into 
distinct lineages. This complex process is regulated by the interaction of multiple 
signaling pathways and transcriptional regulators. Nodal signaling is one of the 
principal players in the process of gastrulation, during which the primary germ layers 
(endoderm, mesoderm, and ectoderm) are formed and organized in their proper 
locations.  
In this introduction I will discuss the roles of Nodal signaling during 
early vertebrate development and the factors that are involved in the transduction and 
regulation of this pathway. I will talk about the nature of morphogens, and how it 
relates to Nodal signaling. Special attention will be paid to two important 
transcription factors in this pathway: Smad2 and FoxH1. I will discuss how these 
factors regulate the expression of Nodal target genes, and the relationship between the 
chromatin state of target genes and their expression. I will pose some of the 
unresolved questions in the field of transcriptional regulation of Nodal-responsive 
genes, and explain how I addressed them in my research.  
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Nodal is a conserved early developmental signal necessary for mesendoderm 
induction and left-right specification 
Some of the most important signaling pathways in animal development 
are those belonging to the TGF-beta superfamily. It is a large family of polypeptides 
with similar structures and similar intracellular signal transduction machinery. This 
superfamily comprises of at least 42 members in vertebrates, and includes TGF-betas, 
bone morphogenic proteins (BMPs), growth and differentiation factor (GDF), 
myostatin, and Nodal signals (Oshimori and Fuchs, 2012). Nodal subfamily is 
considered to be one of the most evolutionary ancient of the TGF-beta superfamily 
members (Pang et al., 2011), and it is present in most metazoans, though notably 
absent from Drosophila and C. elegans (Rebagliati et al., 1998).  
Nodal was one of the first genes knocked out in mice (Zhou et al., 
1993). A retrovirally induced mutation of this gene in mouse led to a failure of 
mesoderm formation. Instead of giving rise to mesoderm, embryonic ectoderm in 
these mutants overproliferated and then rapidly degenerated.  Expression of this gene 
in mouse embryo is highly localized in the node at the anterior of the primitive streak, 
which gave the Nodal gene its name (Zhou et al., 1993). The node in the mouse is 
analogous to chick Hensen's node, dorsal lip in Xenopus, and embryonic shield in 
zebrafish. Mice, as well as humans and birds, have one copy of the Nodal gene, while 
zebrafish have three: squint, cyclops, and southpaw (Erter et al., 1998; Feldman et al., 
1998a; Rebagliati et al., 1998; Sampath et al., 1998). From its first discovery in 1993, 
Nodal signaling has been shown to play crucial role in mesendoderm induction, left-
right patterning, and self-renewal in embryonic stem cells (Conlon et al., 1994; Schier 
and Shen, 2000; Schier, 2009). In the adult organisms Nodal plays an important role 
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in tissue homeostasis and Nodal signaling deregulation is implicated in tumorigenesis 
and metastasis (Strizzi et al., 2012).   
Two of the three Nodal signals, Squint and Cyclops, are expressed 
during gastrulation and dictate mesendoderm formation (Erter et al., 1998; Feldman et 
al., 1998a). These signals are produced at the blastula margin, along with their 
inhibitor Lefty [Fig.1.1]. The third signal Southpaw is expressed later in the 
development and is necessary for the left-right specification.  Nodal signals are 
produced as proproteins, and require the action of proteases to reach their mature 
active form (Le Good et al., 2005).  
 
Figure 1.1 
Schematic representation of a 5-hour post fertilization (5hpf) zebrafish embryo   
Nodal signals (Squint and Cyclops) are produced at the margin and are form an 
animal-vegetal concentration gradient, inducing mesendoderm formation.  
 
 
 
Nodal acts as a morphogen signal 
 
Unlike many signaling systems, which elicit a binary on/off response, 
Nodal signaling belongs to the class of morphogens. Morphogen signals diffuse in the 
extracellular space and can act directly on cells away from the source, producing 
different responses depending on the level of the exposure to the signal.  
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How morphogen gradients are formed and then translated into 
differential target gene expression remains an active research area. In his paper 
written in 1952, Alan Turing proposed a chemical mechanism for the formation of 
biological patterns (morphogenesis) (Turing, 1952), describing a reaction-diffusion 
system that can establish a morphogen gradient in an initially uniform signaling field.. 
In simplistic terms, Turing's original morphogens can be short-range activators 
coupled with long-range inhibitors, each of which acts on itself as well as the other 
(Gierer and Meinhardt, 1972). In the 1960s Lewis Wolpert proposed a positional 
information-based model of how a morphogen could subdivide a tissue into domains 
of different target gene expression (Wolpert, 1969). Such as system has preexisting 
asymmetry that gives rise to a morphogen gradient [Fig.1.2]. While these models 
were often considered to be mutually exclusive, they can in fact be collaborating to 
establish morphogen response systems (Green and Sharpe, 2015). In particular, the 
pattern formed by Nodal and Lefty is a single smooth gradient that is capable of 
providing positional information to every cell, and looks therefore like the Wolpert 
model. However, the gradient itself is created by Turing dynamics, where the short-
range Squint and Cyclops signals interact with the long range Lefty inhibitors (Muller 
et al., 2012).  
The established morphogen gradient must then be translated into 
differential gene expression. Classic models of morphogen interpretation, such as the 
one for Bicoid in Drosophila, are centered on regulation through differential DNA 
affinity (Driever and Nusslein-Volhard, 1988). In this model the regulatory elements 
of low threshold genes have higher affinity for activating factors, and vice versa. 
Recent studies, however, reveal that temporal dynamics play an important role in the 
regulation of Nodal signaling targets (Dubrulle et al., 2015; van Boxtel et al., 2015). 
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These studies show that intrinsic transcription levels of a gene and delays in 
transcriptional onset can have a strong effect on the range of gene expression, and that 
temporal information can be converted into spatial information in the developing 
embryo. 
A. 
     
B. 
                            
Figure 1.2 
Wolpert’s model of morphogen systems  
A) In Wolpert’s positional information model, also known as the French flag model, a 
prior asymmetry results in a graded monotonic distribution of a morphogen. Cells 
then use this distribution to make fate choices, where the concentration and/or the 
duration of the signal that a cell is exposed to dictates the expression of a specific 
gene/genes. Adapted from (Wolpert, 1969).  
B) Nodal signaling in a zebrafish embryo forms a concentration gradient starting at 
the yolk margin. At least two groups of Nodal-responsive genes have been identified: 
high threshold (gsc, sox32) and low threshold (ntla, flh) (Schier and Shen, 2000). 
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Intracellular Nodal signaling transduction 
As with the other TGF-beta superfamily signals, transduction of Nodal 
signaling happens through the phosphorylation of specific serine-threonine kinases.  
Nodal ligands interact with two types of transmembrane receptors, which have 
intrinsic kinase activities in their cytoplasmic domain (Wrana et al., 1994). The 
signaling molecules bind to type II Activin receptors (ActRII/IIB), which leads to the 
recruitment and activation of type I Activin receptors (ALKs) (Tsuchida et al., 2004) 
[Fig.1.3]. Another group required for Nodal signaling in some systems are 
extracellular EGF-CFC proteins, thought to act as coreceptors (Shen and Schier, 
2000).   In zebrafish, the loss of EGF-CFC protein one-eyed pinhead (oep) leads to 
complete loss of Nodal signaling and failure to develop most mesendodermal tissues 
(Gritsman et al., 1999). Successful activation of the Nodal receptors then leads to the 
phosphorylation of Smad2/3 transcription factors and their translocation into the 
nucleus [Fig.1.3] (Massague et al., 2005).  
 
adapted from (Schier and Shen, 2000) 
Figure 1.3  
Intracellular transduction of Nodal signaling 
Binding of the Nodal ligand to the ActRIIB/ALK4 receptors and EGF-CFC 
coreceptors leads to the activation of Smad transcription factors and their 
translocation into the nucleus, where they activate target genes.  
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Transcription factors in Nodal signaling pathway 
The canonical pathway for all TGF-beta superfamily members involve 
the activation of receptor-regulated Smads (R-Smads), with Smads1/5/8 being 
involved in the transduction of the BMP and GDF signals and Smad2/3 – Nodal, 
Activin and TGF-beta signals (Massague, 2012). In their turn, inhibitory Smads 6 and 
7 provide negative feedback (Massague et al., 2005). 
While both Smad2 and Smad3 proteins are expressed in zebrafish 
embryo, early in gastrulation only Smad2 is present and is the main Nodal signal 
transducer necessary for mesendoderm development (Dubrulle et al., 2015).  R-Smads 
can enter the nucleus either as homomeric complexes or in association with Smad4, 
although Smad4 mutant phenotypes are not as severe as those of Smad2/3 loss (Chu 
et al., 2005). Smad2 is provided maternally in zebrafish and its loss leads to a 
phenotype identical to that of complete Nodal signaling loss, where endoderm and 
head and trunk mesoderm are absent [Fig.1.4] (Dubrulle et al., 2015) (Feldman et al., 
1998b). 
 
from (Dubrulle et al., 2015) 
Figure 1.4 
Smad2 is necessary for mesendoderm specification by Nodal signaling 
A) Wild-type embryo at 36hpf B) MZoep embryo: maternal-zygotic mutant for one-
eyed pinhead (oep) (Gritsman et al., 1999). C) MZsmad2 embryo  
D) MZsmad2 embryo rescued with the injection of 20pg of smad2 mRNA.  
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All R-Smads, as well as Smad4, can directly bind to DNA, Smad2 
being the only exception (Massague et al., 2005). Smad3 and Smad4 have relatively 
weak DNA-binding affinity and their preferred binding site has the short motif GTCT 
(Zawel et al., 1998), which is commonly known as a Smad binding element (SBE). 
Many Nodal-regulated genes have one or more SBEs in the sequence of their 
enhancers (Ross and Hill, 2008). Since Smad2 doesn’t have any DNA-binding ability, 
it requires additional sequence-specific transcription factors to recruit it to the 
regulatory loci (Massague et al., 2005).  A number of such transcription factors have 
been identified, such as FoxH1, members of the homeodomain Mix/Bix transcription 
factor family (Mixer, Mezzo), eomesA, HEB, E2A, Oct1, and others (Kikuchi et al., 
2000; Kunwar et al., 2003; Liu et al., 2011; Nelson et al., 2014; Poulain and Lepage, 
2002; Yoon et al., 2011). Many of such transcription factors possess a conserved 
Smad-interacting domain (SID), mediating direct binding between these proteins and 
Smad2/3.    
In order to find bona fide targets of Nodal signaling, it is crucial to 
identify Smad2 binding sites under different exposure conditions. In Chapter III I will 
describe the identification of Smad2 binding sites upon exposure to high levels of 
Nodal signaling, and testing these sites for their functionality.  
 
Role of FoxH1 transcription factor in embryonic development  
FoxH1 factor is one of the most important Smad2 co-factors, 
regulating a large number of Nodal-responsive genes in metazoans (Attisano et al., 
2001). In the mouse, FoxH1 is uniformly expressed in the embryo before and during 
gastrulation, then in the heart up to embryonic day E8.5, and subsequently disappears 
(Weisberg et al., 1998). Mouse Foxh1 mutants display defects in the anterior-
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posterior axis formation, primitive streak patterning, and anterior heart-field 
development (Hoodless et al., 2001; Yamamoto et al., 2001). In zebrafish embryos, 
Foxh1 mRNA is expressed both maternally and zygotically (Sirotkin et al., 2000). 
Early on FoxH1 transcripts are evenly distributed, until the beginning of gastrulation, 
when FoxH1 mRNA is expressed in a ventral to dorsal gradient, with high levels on 
the ventral side and in the shield [Fig.1.5]. The expression of FoxH1 becomes 
progressively restricted to midline and ventral cells, later on being detected 
exclusively in notochord, lateral plate mesoderm and in a stripe of anterior dorsal 
neuroectoderm [Fig.1.5] (Sirotkin et al., 2000). FoxH1 protein is not detected after the 
first day of development. Similar to FoxH1-deficient mouse embryos, zebrafish 
FoxH1 mutants and FoxH1-depleted frog embryos display a loss of organizer and 
axial mesendoderm structures, indicating an evolutionarily conserved role for FoxH1 
(Sirotkin et al., 2000; Slagle et al., 2011). 
     
from (Sirotkin et al., 2000) 
 
Figure 1.5 
FoxH1 expression in early zebrafish embryo 
A) At sphere stage FoxH1 expression is ubiquitous.  
B) At 60% epiboly the gene is expressed in the shield (arrowhead) and in a ventral–
dorsal gradient.  
C) At 90% epiboly the gene is expressed in axial and lateral mesoderm (arrows). 
D) At the one-somite stage the gene is expressed in notochord (arrowhead), lateral 
mesoderm (arrows) and the brain. 
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Pioneer factors in development and in signaling responses 
Most of the nuclear DNA in eukaryotic organisms is inaccessible to 
transcription factors. Their genome is condensed into tightly packed chromatin, first 
by the wrapping of DNA around an octamer of histones to create the nucleosome core 
particle (Kornberg, 1974), then by the binding of linker histone near the nucleosome 
dyad axis (Zhou et al., 1998) and the folding of nucleosomes into higher order 
structures (Schwarz and Hansen, 1994). Indeed, genome-wide analysis of the binding 
of eukaryotic transcription factors always shows that only a small fraction of potential 
binding sites are occupied. One of the ways in which DNA stays or becomes 
accessible to transcription factors is the binding of ‘pioneer factors’ (Zaret and 
Carroll, 2011). This is a special class of proteins that let genes stay competent for 
expression, by accessing their DNA target sites even in compacted chromatin and 
keeping the site accessible for transcriptional activation. Unlike most transcription 
factors, which require cooperativity for binding to their target locus, pioneer factors 
can bind to DNA independent of other factors, and in some cases can recruit histone 
modifying enzymes to make the locus available for other proteins [Fig.1.6]. The 
action of pioneer factors is especially crucial for the regulation of processes that 
require a very rapid response, such as embryonic development or the activation of 
hormonal target genes. In the presence of a pioneer factor the enhancer is already 
marked, giving it a head start towards assembling the transcription preinitiation 
complex (Smale, 2010).  
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from (Zaret and Carroll, 2011) 
Figure 1.6 
Characteristics of a pioneer factor 
While most transcription factors require cooperativity for successful binding, pioneer 
transcription factors can precede the binding of other factors, and can bind chromatin 
independently.  
 
The first protein that was called a pioneer factor was FoxA, which is 
involved in the development of endodermal tissues, enabling liver gene induction 
under the appropriate developmental signals (Cirillo et al., 2002).!E(.+!(/;+6!known 
pioneer factors in mice and other vertebrates are PBX1, TLE, AP2!, GATA factors 
2/3/4, and PU.1. Misregulation of pioneer factor expression often plays a role in the 
development of various types of cancer, making the identification and study of these 
factors all the more important (Jozwik and Carroll, 2012).  
A number of other fork head proteins in addition to FoxA have been 
recognized as pioneer factors, including FoxD3, FoxE1, FoxI1, FoxO3, and FoxM 
(Cuesta et al., 2007; Xu et al., 2007; Yan et al., 2006; Yang and Hung, 2009). A 
common trait of fork head factors is that they contain a winged helix DNA-binding 
domain that mimics the DNA-binding domain of the linker H1 histone, allowing it to 
bind chromatin by interacting with the major groove of only the one available side of 
DNA wrapped around a nucleosome (Clark et al., 1993; Zaret et al., 2010). However, 
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unlike linker histone proteins, fork head domains also possess a helix in their 
structure, allowing for sequence specificity and higher mobility around the 
nucleosome (Sekiya et al., 2009). The active re-arrangement of the nucleosomes 
allows for other transcription factors to bind the available DNA [Fig.1.7]. 
 
 
from (Zaret and Carroll, 2011) 
Figure 1.7 
Forkhead factors possess structural features important for their pioneer factor role 
The crystal structures of the DNA-binding domains of linker histone (Ramakrishnan 
et al., 1993) and FoxA3 (Clark et al., 1993) are shown side by side. The winged helix 
motif makes minor groove contacts along the long axis of the DNA.  
Unlike linker histone, FoxA proteins make specific base contacts that direct target site 
binding and possess an N-terminal trans-activation domain (TAD) (Pani et al., 1992). 
FoxA proteins also possess a C-terminal domain that binds directly to core histone 
proteins and is necessary for the factor to open chromatin (Cirillo et al., 2002). 
 
FoxH1 is an attractive candidate for the role of a pioneer factor in the 
Nodal signaling pathway. It is a fork head family protein, it is provided maternally, 
and there is a very considerable difference between the zygotic and maternal-zygotic 
mutant phenotype, showing that early presence of FoxH1 is crucial for the 
development. Previous experiments also show that the DNA-binding domain of 
FoxH1 is capable of binding to DNA independently (Pogoda et al., 2000). A series of 
experiments combining the DNA-binding FoxH1 domain with an activating (VP16) 
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or a repressing (Engrailed) domain showed that these constructs could activate or 
repress Nodal target genes in the absence of Nodal signals [Fig.1.8]. These 
observations raised a number of questions about the role of FoxH1 in zebrafish 
development. Can the full FoxH1 protein bind to nuclear DNA in the absence of 
Nodal? If so, is Smad2 recruitment its only function, or does it have Nodal-
independent targets? I will address these questions in Chapter II, by analyzing gene 
expression in FoxH1 mutants and identifying FoxH1 binding sites in the presence and 
absence of Nodal signaling.   
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from (Pogoda et al., 2000) 
 
Figure 1. 8 
DNA-binding domain of FoxH1 is able to bind to DNA independent of Nodal 
signaling  
A) Wild-type embryo B) Wild-type embryo injected with 10pg of fkh–en RNA 
developed a phenotype similar to MZoep mutants, including lack of trunk mesoderm 
and cyclopia (arrows mark the head–trunk boundary).  
C) MZoep embryo D) Injection of 5pg of fkh–VP RNA partially rescued the 
formation of somitic mesoderm (arrow) and notochord (arrowhead) in MZoep 
mutants. 
E-F) Rescued muscle-specific expression of myoD in trunk mesoderm in fkh-VP 
injected MZoep mutants, 
G-H) Rescued expression of ntla in fkh-VP injected MZoep mutants. 
I) Constructs used for the experiment: wild-type FoxH1 protein; FoxH1 protein where 
Smad-interacting domain is replaced with VP16 domain; FoxH1 protein where Smad-
interacting domain is replaced with the Engrailed domain. 
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The role of epigenetic marks in development and in signaling responses 
While transcription factors can directly affect gene expression by 
interacting with the general transcription apparatus, they can also recruit various 
enzymes that modify the surrounding chromatin. These enzymes can rearrange the 
nucleosome positioning or modify the histones and DNA itself, leading to activation 
or repression of gene expression (Li et al., 2007). Smad2 and Smad3, for example, 
have been shown to recruit co-activator p300, which is a histone acetyltransferase, to 
gene regulatory elements (Feng et al., 1998; Janknecht et al., 1998). Smad2 interacts 
with a number of other histone-modifying enzymes to modulate the expression of 
Nodal target genes (Ross and Hill, 2008).  
Numerous mapping studies have detected correlations between the 
chromatin state of a gene and its levels of expression (Fisher and Fisher, 2011; 
Siggens and Ekwall, 2014), and knockout experiments show that loss of histone-
modifying proteins leads to developmental abnormalities. For example, the Polycomb 
group proteins in the PRC2 complex di- and tri-methylate H3K27 and are required for 
embryo viability and normal gene expression during embryonic stem (ES) cell 
differentiation (Erhardt et al., 2003; Faust et al., 1998, 1995).  
Enhancer elements experience a change in chromatin structure upon 
being primed for and the actual activation of the gene it regulates. H3K9me3 mark is 
associated with silent enhancers, H3K27me3 – with silent or poised ones, and 
H3K4me1 with poised enhancers only (Bonn et al., 2012; Rada-Iglesias et al., 2011; 
Zhu et al., 2013, 2012). On the other hand, acetylation of H3K27 residue (H3K27ac) 
is a mark of active enhancers (Creyghton et al., 2010) [Fig.1.9].  
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INACTIVE STATE &
Repressed chromatin is associated with the presence of H3K27me3 and H3K9me3 
marks, binding of Polycomb group (PcG) proteins, DNA methylation and compact 
nucleosome positioning.  
 
POISED STATE      
 
Poised enhancers and promoters still have H3K27me3 histone marks and PcG 
proteins bound on them, but there is an overall less compact chromatin structure and 
lack of DNA methylation. Poised promoters are associated with H3K4me3, and 
poised enhancer with H3K4me1 histone marks. Pioneer factors may be bound to 
poised enhancers.  
 
ACTIVE STATE   
 
Active promoters lose H3K27me3 mark. Active enhancers lose H3K27me3 
modification and are marked by H3K4me1 and H3K27ac.  
 
 
Figure 1.9 
Chromatin structure and its modifications reflect and govern the transcriptional state 
of the associated genes 
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A number of marks exhibit very strong association with either silenced 
(e.g. H3K27me3) or active (e.g. H3K4me3) gene promoters (Rando, 2007). However, 
some genes contain both activating and repressing marks at their promoters 
(combination of H3K27me and H3K4me3), and it has been proposed that this 
combination of marks keeps genes turned off but poised for activation (Bernstein et 
al., 2006; Vastenhouw and Schier, 2012). Important developmental genes, such as 
genes activated by patterning signals, often possess such bivalent marks (Bernstein et 
al., 2006; Vastenhouw and Schier, 2012). Studies in cell culture show that many 
Nodal-regulated genes are bivalent in embryonic stem cells, and the bivalent mark 
resolves upon activation of the genes. The levels of the silencing H3K27me3 mark are 
reduced and levels of H3K4me3 mark go up in response to Nodal exposure (Kim et 
al., 2011) [Fig.1.9].  
How Nodal signaling affects chromatin affects chromatin landscape of 
its target genes has not yet been studied in a developing embryo, and it is unclear 
whether the process is identical to that in cell culture. It is also unknown whether 
simply getting rid of a silencing mark is sufficient to change the expression of a Nodal 
target gene. I will address these questions in Chapter IV, as I study the distribution of 
H3K4me3 and H3K27me3 marks in embryos with and without Nodal signal 
exposure, and test the effect of targeted H3K27me3 mark reduction on the expression 
of a Nodal target gene.   
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Overview 
The regulation of transcriptional response to signaling is important for 
our understanding of all areas of biology, from basic embryonic development to 
biomedical applications. A great deal of research has been done in the area in the past 
several decades, but there are still many questions to be answered. In particular, as 
many studies are done in cell culture, it is often unclear whether these findings hold 
true in an actual developing organism. Experiments done is zebrafish, a vertebrate 
fast-developing organism, thus become especially important. As misregulation of 
Nodal signaling is implicated in tumorigenesis and metastasis in a number of cancer 
types, studying this signal has biomedical significance.  
My research described in the following chapters concerns the 
transcriptional regulation of Nodal target genes in an early zebrafish embryo. I studied 
the process of transcription factor assembly on Nodal regulated enhancers, focusing 
on FoxH1 and Smad2 factors, and the chromatin modification changes at the 
promoters of Nodal target genes. In Chapter II I study the role that FoxH1 plays in the 
regulation of Nodal target genes, as well as its potential Nodal-independent target 
genes. Chapter III describes the identification of Smad2 binding sites upon 
oversaturation of the system with Nodal signaling and discovery of novel Nodal target 
genes. In Chapter IV I describe the chromatin state of Nodal target genes in the 
presence and absence of Nodal signaling, and the use of Cas9-based tools for targeted 
reduction of H3K27me3 mark.   
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CHAPTER II  
Analysis of FoxH1 function and target genes  
 
ABSTRACT 
In this chapter I will talk about in depth analysis of FoxH1 function and its target 
genes. FoxH1 has been shown to play a range of roles, including Nodal-independent 
ones, in early vertebrate development in various model organisms (Chiu et al., 2014; 
Silvestri et al., 2008). I generated a complete mutant of this transcription factor and 
used deep sequencing to identify which genes FoxH1 regulates in zebrafish 
development. I did not detect a pre-gastrulation phenotype in these mutants, contrary 
to observations made in FoxH1 morphants (Pei et al., 2007). Using ChIP-Seq 
experiments, I also found the binding sites of FoxH1. I found that FoxH1 is capable of 
binding to genomic DNA in the absence of Nodal signaling, which suggests that it 
may act as a pioneer factor, preparing target genes for rapid activation when 
gastrulation starts. I also found 54 direct FoxH1 target genes that are not Nodal-
dependent. Genes involved in nervous system development were overrepresented in 
this group.  
 
PREFACE 
I designed, performed, and interpreted all experiments. Summer Thyme generated the 
Cas9 protein and targeting RNA used to create the FoxH1 mutants, and provided help 
during the mutant generation process. The Burdine lab generously provided the 
midway fish. Smad2 and FoxH1 ChIP-Seq data has been previously published in 
(Dubrulle et al., 2015). Alexander F. Schier helped conceive, design, and support the 
project.  
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INTRODUCTION  
FoxH1 (Fast1, fork head activin signal transducer 1), is a winged helix 
transcription factors that was first discovered as a mediator of Activin-like signaling 
in conjunction with Smad2/3 (Chen et al., 1996). It has been well studied in cell 
culture and in Xenopus embryos, where it was shown to also function independently 
of Nodal signaling (Chiu et al., 2014; Kim et al., 2011; Silvestri et al., 2008). Two 
zebrafish mutants for the FoxH1 transcription factor have been created and analyzed 
so far. However, both of the published mutants, schmalspur (sur) (Kunwar et al., 
2003) and midway (mid) (Slagle et al., 2011), do not get rid of the protein completely, 
but rather create a single amino-acid DNA-binding site mutation and a truncated 
version of the protein, respectively [Fig.2.1]. Comparison between sur and mid 
phenotypes suggested that sur is a hypomorphic allele. This was tested by injecting 
wild-type and mutant embryos with 50 pg of squint mRNA at one-cell stage, fixing 
them at 30–50% epiboly, and then visualizing the expression of ntla and gsc genes. 
While wild-type and MZsur embryos upregulated both targets ubiquitously, MZmid 
embryos exhibited a much weaker Nodal-dependent activation of both genes.  
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A. 
   
B. 
  
Figure 2.1 
FoxH1 transcription factor in zebrafish and its published mutants  
A) FoxH1 transcription factor binds to enhancer region of a regulated gene containing 
the consensus sequence {AATAMACA} and recruits activated phosphorylated 
Smad2 factors, which in their turn interact with Smad binding elements in a weak 
manner. 
B) (from (Slagle et al., 2011)) Schematic representation of the wild type FoxH1 
factor, with DNA-binding domain shown in red, and Smad-interacting domain (SID) 
shown in green.  
sur mutant variant cannot independently bind to DNA because of a missense mutation 
in the DNA-binding domain, but could potentially be stabilized at a loci in the 
presence of activated Smad complexes.  
mid mutant variant possesses a frame-shift mutation leading to a truncation right 
before SID, but the protein is not completely removed from the cell, leaving the 
possibility of residual activating or repressive ability.  
 
As the DNA-binding domain of FoxH1 is unperturbed in mid mutants, 
there is a possibility that some function remains. Since in the mid fish Smad-binding 
domain of FoxH1 is removed, the remaining part of the protein might even act as a 
repressor of the genes that it normally activates. A study of zebrafish FoxH1 
morphants (Pei et al., 2007), for example, suggests that FoxH1 has an early 
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requirement for maternal FoxH1 during gastrulation that is not observed in mid 
mutants [Fig.2.2]. We therefore created new mutant alleles of FoxH1, to completely 
get rid of this protein and all its domains. We then analyzed this mutant to fully 
understand the function of FoxH1 in early zebrafish development.  
A.                                                                      B. 
    
from (Pei et al., 2007) 
 
Figure 2.2 
FoxH1 morphant exhibits an early gastrulation phenotype  
A) Injection of FoxH1 translation-blocking morpholino, but not control morpholino, 
disrupts embryonic epiboly movements during gastrulation and causes death on the 
first day of development.! Apart from disrupting epiboly, FoxH1 MO treatment 
disrupts convergence and internalization movements. 
Top to bottom: phenotype of an uninjected embryo, embryo injected with control 
MO, and FoxH1 translation-blocking MO.  
Left to right: shield, 3-somite, and 10-somite developmental stages. 
B) Morphant phenotype can be rescued by co-injection of FoxH1 mRNA 
Top to bottom: phenotype of embryo injected with control MO, injected with FoxH1 
MO and coinjected with FoxH1 MO and FoxH1 mRNA.  
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RESULTS 
FoxH1 mutant generation and allele description 
In order to generate a complete FoxH1 mutant, we used Cas9-mediated 
targeted mutagenesis. To make sure that all possible isoforms will be mutated, we 
targeted 3 different regions in the foxH1 gene, one in each of the exons of the gene 
[Fig.2.3.A]. Multiple gRNAs were designed in order to target each of these regions. 
Summer Thyme performed the design of these gRNAs and the initial injection of 
those together with Cas9 protein at 1-cell stage of the embryos, as previously 
described (Gagnon et al., 2014). We obtained alleles containing frame-shift mutations 
at each of the targeted locations. Heterozygous embryos survived to adulthood and 
were crossed together to obtain homozygous fish.  
A. 
  
B.   
  
C.   
  
Figure 2.3  
FoxH1 mutant generation using Cas9-mediated mutagenesis 
A) Targeted sites in FoxH1 gene in the first, second and third exons.  
B) Sequence alignment results showing a 7bp deletion in exon 1.  
C) Sequence alignment results showing a 16bp deletion in exon 3. 
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For in depth analysis, we focused on two alleles, both with a frame-
shift mutation: one a 7bp deletion in exon 1, another a 16bp deletion in exon 3 
[Fig.2.3.B-C]. Zygotic homozygous fish with either allele exhibited defects in 
development, such as severe ventral body curvature, and did not survive past 4 days 
[Fig.2.4]. These homozygous fish could be rescued by injection of 10pg of FoxH1 
mRNA at 1-cell stage. The rescued embryos developed normally, and crossing them 
generated maternal-zygotic (MZ) mutant progeny. All analysis hereafter has been 
done using the allele with a frame-shift mutation in exon 1 of the gene (E1 mutant).  
 
A.                                                                    B. 
                
 
 
Figure 2.4:  
Zygotic homozygous FoxH1 E1 mutant embryo 
A) Zygotic homozygous E1 mutant embryo at 48hpf. These embryos exhibit severe 
developmental abnormalities and do not survive past 4 days.  
B) For comparison, wild type, zygotic sur and maternal-zygotic homozygous sur 
embryos are shown on the right (from (Kunwar et al., 2003)). 
 
FoxH1 maternal-zygotic mutant phenotype  
Contrary to what experiments with FoxH1 morpholino suggested, I 
observed no pre-gastrulation phenotype in MZE1 embryos (Pei et al., 2007). Embryos 
started exhibiting differences from wild type ones only at shield stage (6hpf). At 
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24hpf, these embryos consistently displayed an absence of notochord and very close-
set eyes (often full cyclopia), hallmarks of Nodal signaling deficits [Fig.2.5].  
A.      wild-type  || E1 zygotic mutant ||    E1 maternal-zygotic mutants     
 
           
 
B.       wild-type  || E1 zygotic mutant ||    E1 maternal-zygotic mutants     
 
            
 
C.       wild-type  || E1 zygotic mutant ||    E1 maternal-zygotic mutants      
 
            
 
Figure 2.5  
FoxH1 maternal-zygotic E1 mutant phenotype  
A) Whole embryo view: shortened trunk and underdeveloped head are clearly visible. 
B) Front head view: closely set eyes, partial or complete cyclopia is present in all MZ 
mutants.  
C) Side trunk view: poorly developed somites and absence of notochord are visible. 
 
 
Among several clutches observed (~300 embryos in total), no embryo 
without any phenotypic abnormalities was observed, and none survived past 4 days. 
The defects that we observed were not significantly more severe than the ones 
described in the midway mutants [Fig.2.6]. Considering the fact that both the 
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previously generated mutant midway and the complete FoxH1 E1 mutant failed to 
exhibit a pre-gastrulation phenotype, we can conclude that the morpholino phenotype 
is likely not a consequence of FoxH1 missing, but rather a side-effect of the injection 
of this morpholino. 
A.         wild-type    ||     MZsur     ||    MZmid    || MZ E1 mutant  
             
B.          wild-type      MZE1 mutant                   wild-type     MZE1 mutant      
                               
                 
                          flh in situ                                             gsc in situ 
 
Figure 2.6  
Side-by-side comparison of the MZ midway mutant and MZE1 mutant  
A) Whole-body (above) and trunk (below) phenotype of wild-type, MZsur, MZmid 
(from (Slagle et al., 2011)) and MZE1 embryos.  
B) in situ hybridization pictures of the expression of two Nodal-regulated genes, flh 
and gsc, at shield stage. Wild-type and MZE1 mutant embryos above, wild-type and 
MZmid embryos below (from (Slagle et al., 2011)).  
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Identification of the direct targets of FoxH1 in zebrafish 
Although FoxH1 has long been known as a transcription factor crucial 
for early development in all vertebrates, only a limited number of direct targets of this 
factor were identified in zebrafish (Sirotkin et al., 2000; Slagle et al., 2011). Several 
papers proposed that FoxH1 in other organisms might have a function in development 
other than the recruitment of Smad2 to Nodal target genes (Chiu et al., 2014; Silvestri 
et al., 2008). Only a few of those, however, have been found in zebrafish so far (Pei et 
al., 2007; Slagle et al., 2011).  
In order to identify many or all FoxH1 targets in zebrafish embryo, I 
sequenced mRNA from wild type and MZE1 mutant embryos at dome stage (4hpf) 
using deep sequencing. After analyzing the data, I obtained a list of 1660 unique 
genes with significantly different expression levels (q<0.05) between these two 
groups. Applying the cutoff of 2-fold difference in either direction (increase or 
decrease in expression), 92 genes were found to be upregulated in MZE1 mutant 
embryos, while 457 genes were downregulated.  
To find out which of these genes are directly regulated by FoxH1, I 
performed ChIP-Seq of FoxH1 transcription factor using dome stage embryos. I 
performed chromatin immunoprecipitation (ChIP) with an anti-flag antibody in 
embryos expressing FoxH1-flag construct. Nodal signaling in the analyzed embryos 
was either blocked by drug addition (DR), overactivated by the injection of high 
levels of squint mRNA (SQ), or unperturbed (WT). The validity of the data is 
supported by the fact that FoxH1 binding peaks are enriched in the proximity of 
known Nodal target genes, and overlap with enhancer-specific chromatin marks 
(H3K4me1, H3K27ac (data from (Bogdanovic et al., 2012)) [Fig.2.7].  
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Gene name: ntla 
 
 
Gene name: lft2 
 
Figure 2.7 (continued on the next page) 
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Figure 2.7 (continued) 
 
Gene name: lhx1a 
 
Figure 2.7 
ChIP tracks for FoxH1 transcription factor binding and enhancer chromatin marks 
For each gene, top to bottom, the following tracks are shown:  
FoxH1 factor binding in embryos coinjected with squint mRNA; results of peak 
calling on this track; FoxH1 factor binding in embryos treated with Nodal drug 
inhibitor; results of peak calling on this track; H3K27ac and H3K4me1 ChIP tracks at 
dome stage (from (Bogdanovic et al., 2012)). 
 
Motif discovery tools identify FoxH1 consensus binding sequence in 
the FoxH1 peaks, as well as those of Oct-family proteins and Smad2/3 binding 
sequences [Fig.2.8]. Of note, 15.4% of FoxH1 binding peaks also contained the 
common binding motif for Zic1/2/3 transcription factors [Fig.2.8]. Zic family of zinc-
finger proteins has been shown to play an important role in animal development. In 
pluripotent cells Zic3 is required for maintenance of stem cells pluripotency upon 
binding to promoters of genes associated with cell pluripotency (Nanog, Sox2, Oct4, 
etc.) as well as cell cycle, proliferation, oncogenesis and early embryogenesis (Lim et 
al., 2010, 2007). In contrast, during gastrulation and neurulation Zic3 acts by binding 
the enhancers associated with control of gene transcription in the Nodal and Wnt 
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signaling pathways (Winata et al., 2013). Zic family proteins also often bind to 
adjacent sites in the context of multi-transcription factor complexes associated with 
regulatory elements.  
 
 
Figure 2.8  
FoxH1 peaks de-novo motif analysis 
Transcription factor binding motif analysis identified consensus binding sequences for 
FoxH1, Smad2/3, Zic and Oct-family members.   
 
ChIP-Seq data from dome stage drug-treated embryos confirms that in 
most cases FoxH1 binding to the regulatory elements does not require Nodal 
signaling. The fact that FoxH1 is capable of binding to DNA early on in development, 
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and before any exposure to the Nodal signal, and can later recruit the activating R-
Smad complex, indicates that FoxH1 can be considered a pioneer factor. 
We were interested in determining whether there is a correlation 
between FoxH1 binding and the observed threshold of the nearest gene activation.  I 
used MACS2 software to identify the number and position of FoxH1 peaks near genes 
that are low and high threshold. I did not find a significant difference in number and 
position of such peaks between these groups of genes. This suggests that FoxH1 
doesn’t play an important role in the determination of activation threshold of Nodal 
target genes. It is likely that other transcription factors play a role in this regulation.  
 
FoxH1 functions in the regulation of genes that are not Nodal targets 
Out of the 549 genes that changed their expression in MZE1 mutant 
embryos, 84 genes had FoxH1 peak within 20kb of their transcription start site (TSS), 
suggesting that these are direct FoxH1 targets [Table 2.1]. Of these, 13 were 
upregulated and 71 downregulated in MZE1 mutants.  25 of these 84 genes also had a 
Smad2 peak within 20kb of the TSS, among them well known Nodal target genes, 
such as gsc, lft1, foxa2.  In addition, 11 of these 84 genes were identified as Nodal-
regulated by previous research based on expression studies (Bennett et al., 2007). This 
adds up to 30 genes, where the main role of FoxH1 is most probably the recruitment 
of activated Smad2. Gene ontology analysis of this group showed that the following 
groups of genes were overrepresented, among others: axis elongation (GO:0003401); 
regionalization (GO:0003002); pattern specification process (GO:0007389); cell 
differentiation (GO:0030154).  These groups were not overrepresented in the analysis 
of FoxH1 regulated genes that are not Nodal target genes. In contrast, the following 
classes of genes were overrepresented: cell morphogenesis involved in neuron 
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differentiation (GO:0048667); axon development (GO:0061564); cell migration 
(GO:0016477); neuron projection development (GO:0031175); localization of cell 
(GO:0051674); cell motility (GO:0048870). 
 
Table 2.1  
FoxH1 direct target genes, based on RNA-Seq and ChIP-Seq analysis 
 
Gene 
name 
fold change 
log2 Gene name 
fold change 
log2 Gene name 
fold change 
log2 
angptl4 -4.01477 alcamb 2.15064 serinc5 2.88414 
her3 -3.72952 lemd3 2.1873 fzd7b 2.91004 
krt91 -2.75941 sec61a1l 2.19379 tuba1a 2.9283 
lim2.3 -2.61858 fgfr1b 2.19773 mfsd11 2.9562 
her7 -2.44526 sdc4 2.19815 amfr 2.98414 
klf17 -2.22545 lpgat1 2.24156 serpina10a 3.0143 
nfil3 -2.19859 ptger4b 2.29186 relt 3.04513 
znf143b -2.19601 aoc2 2.29757 erlin1 3.08424 
meig1 -2.14454 itm2cb 2.30848 igf2a 3.16639 
h2afx -2.13372 cxcr4b 2.31706 tmbim1 3.21415 
lama4 -2.11796 p4ha2 2.32752 atp1b1a 3.22063 
her6 -2.10744 bbc3 2.33893 slc16a1b 3.37816 
krt18 -2.07604 acvr2aa 2.3458 cdkn1a 3.43378 
gsc 1.91994 atp1a1a.1 2.36129 pkd2 3.50687 
aplnra 1.92861 itgb5 2.38941 itga5 3.52659 
kif1b 1.94021 tspan7b 2.4009 sfrp1a 3.55539 
susd6 1.95375 bcap29 2.41366 gpc4 3.66187 
hmgxb4a 2.0121 slc35e3 2.42683 abca1a 3.69615 
gde1 2.01453 tmem2 2.42891 cntn2 3.82175 
spint2 2.01547 acvr1ba 2.42922 adam10a 3.83637 
wee2 2.07031 kazald2 2.47959 notch3 3.90263 
golim4b 2.0754 ctsc 2.53773 aplnrb 4.0503 
bri3bp 2.08561 bmp7a 2.54617 foxa2 4.09775 
tmem9b 2.10248 alpl 2.56549 lamc1 4.37879 
slc39a6 2.10968 cx43.4 2.57884 clstn1 4.73137 
dhrs9 2.10976 gyltl1b 2.61633 notum1a 5.51099 
tph1b 2.12944 glipr2l 2.70213 ptk7a 5.54227 
cmtm7 2.13001 ptprfb 2.77218 lft1 5.73446 
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These results are in agreement with the results observed in other 
organisms and in FoxH1 morphants in zebrafish.  One study in mouse embryos 
revealed that FoxH1 initiates a transcriptional regulatory network within the 
developing anterior neuroectoderm and plays a role in initiating retinoic acid 
signaling in the forebrain (Silvestri et al., 2008). Another recent study in Xenopus 
embryos identified 72 FoxH1 targets that lack Smad2/3 binding and are insensitive to 
Nodal signaling inhibition. 27 of these genes are upregulated in the absence of 
FoxH1, suggesting that FoxH1 functions as a dual-acting TF to activate or repress 
target genes in a Nodal-independent manner (Chiu et al., 2014).  
In zebrafish, apart from disrupting epiboly, FoxH1 MO treatment 
disrupted convergence and internalization movements and disrupted the expression of 
five keratin genes – cyt1, cyt2, krt4, krt8 and krt18 - that are normally transcribed in 
the embryo’s enveloping layer. Our results found two keratin genes to be disrupted: 
krt18 and krt91. However, in contrast to the previous results, we did not observe 
severe abnormalities in cell movement during epiboly. In fact, the morphology was 
normal until shield stage. At 24hpf, the development of brain, eyes and somites was 
disrupted in MZE1 mutants, but not as dramatically as in morphants (Pei et al., 2007). 
Similar to the results in mice, FoxH1 was shown by us to regulate a number of genes 
that are important in the development of the nervous system.  As in Xenopus embryos, 
FoxH1 was shown by our study to downregulate a number of genes. 8 out of the 13 
downregulated genes are transcription factors, functioning in the development of 
heart, brain, and blood circulation.  3 more encoded structural proteins in epidermal 
cells, blood vessels, and lens.  
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DISCUSSION  
FoxH1 has been identified as one of the key factors in mesendoderm 
development. Although mutations of this transcription factor do not abrogate Nodal 
signaling entirely, they lead to severe loss of mesendodermal tissues (Hoodless et al., 
2001; Yamamoto et al., 2001). Two different mutants and a morphant have been 
generated for FoxH1 in zebrafish, but it was still unclear whether complete loss of its 
function had been achieved. Using Cas9 technology, we have been able to generate 
alleles with a frame-shift mutation early in the transcript for in depth analysis of this 
transcription factor.  
We identified a number of FoxH1 target genes that are not Nodal-
regulated, while we didn’t detect any phenotypic defects in the FoxH1 mutant that 
were drastically different from those in MZoep mutants. It must be noted, however, 
that many of the Nodal-independent FoxH1 target genes are involved in the 
development of the nervous system. Since early defects in Nodal signaling 
transduction lead to abnormalities in head and brain development, these could easily 
mask the later Nodal-independent role of FoxH1. Our analysis of FoxH1 target genes 
also identified two keratin genes: krt18 and krt91, similarly to the findings in FoxH1 
morphant (Pei et al., 2007). Contrary to their results, however, we did not observe a 
disruption in epiboly, convergence and internalization movements. It can be explained 
by the fact that morpholino decreased the expression of five keratin genes – cyt1, 
cyt2, krt4, krt8 and krt18 – unlike the two in FoxH1 mutant. We hypothesize that 
morpholino had off-target effects on keratin genes that we did not find to be disrupted 
in the mutant. While other keratin genes can compensate for the loss of krt18 and 
krt91 in FoxH1 mutants, they are unable to do so when FoxH1 morpholino was 
injected.   
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In addition to the 71 genes that had a FoxH1 binding site near their 
TSS and were downregulated in FoxH1 mutants, we found 13 that were upregulated, 
suggesting that FoxH1 can also act as a repressor. 8 out of these repressed genes are 
transcription factors, functioning in the development of heart, brain, and blood 
circulation, and 3 are structural proteins in epidermal cells, blood vessels, and lens. 
This is consistent with previous observations that overexpression of FoxH1 has a 
negative effect on vascular formation in zebrafish embryos (Choi et al., 2007).  
The mechanism of FoxH1 repressive activity has to be studied further. 
Many transcription factors in fork head family of proteins can mediate gene 
repression through recruitment of TLE/Groucho family transcriptional corepressors 
(Yaklichkin et al., 2007) and FoxH1 has  a conserved Engrailed homology-1 (EH1) 
motif. Studies in mouse, however, showed that disrupting FoxH1–Groucho 
interaction through mutations in this domain do not lead to significant gene 
expression changes (Halstead and Wright, 2015). While it is possible that recruitment 
of transcriptional repressors can happen without the EH1 domain, it is also possible 
that FoxH1 competes for binding with activating factors, and represses gene 
expression in this manner.  
To regulate Nodal-independent genes, FoxH1 should be capable of 
binding to DNA in the absence of Nodal signaling. This is indeed what we observed 
in our ChIP experiments. The majority of FoxH1 binding peaks were present with or 
without Nodal signaling. One caveat of our experiments is that we didn’t use an 
antibody against the endogenous FoxH1 protein. Testing showed that the levels of 
FoxH1-flag mRNA we injected didn’t cause any developmental abnormalities, 
suggesting that we didn’t flood the embryo with FoxH1, which could have lead to 
improper binding. However, using an antibody against endogenous FoxH1 or using 
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transgenic zebrafish that express a FoxH1-flag construct under a native promoter 
would be ideal for further experiments with this transcription factor. This setup could 
be used to determine the earliest point at which FoxH1 binds to its target loci, since 
maternally provided FoxH1 should be present in the embryos long before zygotic 
genome activation.  
 The fact that FoxH1 binds to enhancers without Nodal signaling and 
later recruits Smad2 to these loci suggests that FoxH1 plays the role of a pioneer 
factor. Previously identified pioneer factors often play roles in modifying/remodeling 
histones and changing/maintaining DNA methylation status (Heinz et al., 2010; Xu et 
al., 2009, 2007). ChIP studies in FoxH1 mutants can show whether it plays similar 
roles in regulating chromatin landscape. DNA methylation and nucleosome density 
profile, the status of H3K4me1, H3K4me2, and H3K9me3 marks can be compared 
between wild-type embryos and FoxH1 mutants.  
Our study identified a number of novel FoxH1 target genes, some of 
them activated and some repressed by this transcription factor. We also found 54 
FoxH1 target genes that are not Nodal-regulated. Study of FoxH1 binding sites helped 
us identify other transcription factors that it potentially interacts with, and gave us 
data on which Smad2 peaks are associated with FoxH1 binding, which is important 
for better understanding of Nodal signaling.  
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MATERIALS AND METHODS 
 
FoxH1 mutant generation:  
Target sites that matched the sequence GG-N19-GG, GA-N19-GG, or AG- N19-GG 
were selected in the first, second and third exon of the FoxH1 gene, and checked for 
uniqueness in the genome. To generate templates for sgRNA transcription, gene-
specific oligonucleotides containing the T7 promoter sequence, the 20 base target site 
without the PAM, and a complementary region were annealed to a constant 
oligonucleotide encoding the reverse-complement of the tracrRNA tail. sgRNA 
templates were purified using Qiaquick columns (Qiagen) and transcribed using 
Megascript kit (Ambion). All sgRNAs were then DNase treated and precipitated with 
ammonium actetate/ethanol. Cas9 mRNA was transcribed from linearized template 
DNA using mMachine SP6 kit (Ambion), DNase treated, and precipitated with 
lithium chloride. Zebrafish TLAB strain zygotes were collected and injected through 
the chorion with a mix of 25 pg sgRNA, 300 pg Cas9 mRNA, and phenol red dye in a 
single mix. The resulting F0 generation zebrafish were grown to adulthood, and their 
progeny from a cross to WT fish were sorted using MiSeq to identify frame-shifting 
indel mutations. F1 embryos containing the required mutations were grown to 
adulthood and crossed to each other to obtain homozygous fish. To rescue zygotic 
homozygous FoxH1 embryos, 10pg of FoxH1 mRNA was injected through the 
chorion at one-cell stage. FoxH1 mRNA was obtained from full-length zebrafish 
FoxH1 cDNA cloned into pcs2+ plasmid and transcribed using mMachine SP6 kit 
(Ambion).  
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Chromatin Immunoprecipitation (ChIP) 
Embryos for ChIP were collected at dome stage after 5 pg squint mRNA injection or 
after treatment with the Nodal signaling inhibitor SB505124 (Sigma S4696) at 20 µM 
final. For FoxH1 ChIP, embryos were injected with 5 pg of FoxH1-flag mRNA at 1-
cell stage, and anti-flag antibody was used for the pull down. For each ChIP, 800 
embryos were collected and fixed in 1.85% formaldehyde for 15 min at 20˚C. 
Formaldehyde was quenched by adding glycine to a final concentration of 0.125 M. 
Embryos were rinsed three times in ice-cold PBS, and resuspended in cell lysis buffer 
(10 mM Tris-HCl pH7.5/10 mM NaCl/0.5% NP40) and lysed for 15 min on ice. 
Nuclei were collected by centrifugation, resuspended in nuclei lysis buffer 
(50mMTris-HCl pH 7.5/10mMEDTA/1% SDS) and lysed for 10 min on ice. Samples 
were diluted three times in IP dilution buffer (16.7 mM Tris-HCl pH 7.5/167 mM 
NaCl/1.2 mM EDTA/ 0.01% SDS) and sonicated to obtain fragments of !500 bp. 
Triton X-100 was added to a final concentration of 0.75% and the lysate was 
incubated overnight while rotating at 4˚C with 25 µlof protein G magnetic Dynabeads 
(Invitrogen) pre-bound to an excess amount of antibody. Antibody used was anti-
FLAG M1 (Sigma F3165). Bound complexes were washed six times with RIPA (50 
mM HEPES pH7.6/1 mM EDTA/0.7% DOC/1% Igepal/0.5 M LiCl) and TBS and 
then eluted from the beads with elution buffer (50 mM NaHCO3/1% SDS). 
Crosslinks were reversed overnight at 65˚C and DNA purified by the QIAquick PCR 
purification kit (Qiagen).  
 
ChIP-qPCR 
ChIP was done as described above. Embryos were injected with 5 pg of FoxH1-flag 
mRNA at 1-cell stage, and collected at 1K-cell stage. The eluted DNA was analyzed 
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using SYBR® Green I (BioRad) and DNA Engine Opticon System (MJ Research) 
with technical duplicates. ChIP enrichment was normalized to input, and plotted as 
fold enrichment over input.  
 
ChIP-Seq 
ChIP was performed as described above. Embryos were untreated, incubated at 1-cell 
stage with 10mM Nodal inhibitor drug SB-505124 (DaCosta Byfield et al., 2004) 
(S4696 SIGMA), or injected at 1-cell stage with 5pg of squint mRNA. Libraries were 
prepared according to the Illumina sequencing library preparation protocol and 
sequenced on an Illumina HiSeq 2000. Reads were aligned to Danio rerio genome 
Zv9 assembly using. ChIP-seq reads were mapped using Bowtie (v.0.12.9) 
(Langmead, 2010); peaks were called using MACS (v.2.0.10) (Zhang et al., 2008). De 
novo motif analyses used XXMOTIF (Hartmann et al., 2013). JASPAR public 
database was used to find candidate proteins. GO analyses were performed using 
PANTHER (protein annotation through evolutionary relationship) classification 
system (Mi et al., 2013).  
 
RNA-Seq  
Approximately 100 embryos at dome stage were dechorionated, and whole RNA was 
extracted from them using TRIZOL, according to the manufacturer’s protocol. mRNA 
was isolated using poly-A tail isolation method, libraries were prepared according to 
the Illumina sequencing library preparation protocol, and sequenced on an Illumina 
HiSeq 2000. Differential gene expression analysis of RNA-seq data was performed 
using TopHat (v. 1.3.3) (Trapnell et al., 2009) and Cuffdiff (v. 1.3.0) (Trapnell et al., 
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2012). GO analyses were performed using PANTHER (protein annotation through 
evolutionary relationship) classification system (Mi et al., 2013). 
 
RT-qPCR 
For gene expression analysis, total RNA was isolated from approximately 20 
zebrafish embryos using QIAgene RNeasy kit. cDNA was made from total RNA 
using BioRad iScript kit, and analyzed using SYBR® Green I (BioRad) and DNA 
Engine Opticon System (MJ Research). A housekeeping gene β-actin was used for 
normalization across samples.   
 
In situ hybridization 
In situ hybridization on whole mount embryos was carried out using standard 
methods. Embryos were fixed in 4% formaldehyde overnight, and then dehydrated, 
rehydrated, and stained. Following staining, embryos were cleared in benzyl 
benzoate/benzyl alcohol (2:1 vol/vol) and imaged.  
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CHAPTER III   
Identification of Smad2 binding sites and regulatory elements 
 
ABSTRACT 
Identifying regulatory elements that recruit Smad2 is crucial for our understanding of 
Nodal signaling pathway. In this Chapter I describe experiments performed towards 
this goal. I carried out Smad2 ChIP-Seq in embryos overexpressing Nodal signal 
Squint, thus detecting loci that bind Smad2 after exposure to high Nodal levels. I 
found 1041 such peaks, enriched for the binding motifs of Smad2/3, FoxH1, EomesA, 
Oct and Homeobox family proteins, as well as a negative regulator Osr1. I tested 
DNA elements of approximately 500bp centered on a Smad2 binding peak for their 
gene regulatory potential, and discovered that they are sufficient to drive gene 
expression in a Nodal-dependent manner. I also identified 26 previously unpublished 
Nodal target genes, and 55 genes that are bound by Smad2 upon exposure to high, but 
not low levels of Nodal signaling.  
 
PREFACE 
I designed, performed, and interpreted all experiments. Andrea Pauli 
generated RNA-Seq data in Squint-injected and MZoep zebrafish. The Gomez-
Skarmeta lab generously provided ZED vector. Smad2 and FoxH1 ChIP-Seq data has 
been previously published in (Dubrulle et al., 2015). Alexander F. Schier helped 
conceive, design, and support the project.  
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INTRODUCTION  
The recruitment of phosphorylated Smad2 to DNA is considered to be 
the final event necessary for the activation of Nodal-regulated genes, an on-off switch 
for gene transcription initiation. It has therefore been assumed (but not proven) that 
binding conditions of Smad2 transcription factor are different between genes with 
higher vs. lower threshold of activation. If this assumption is true, other factors should 
be responsible for determining the conditions under which Smad2 will be recruited to 
the locus, since Smad2 is incapable of binding to DNA by itself. These determining 
factors could be the sequence-specific co-transcription factors, such as FoxH1 and 
Mixer, or the chromatin landscape of the locus, including nucleosome occupancy.   
Chromatin immunoprecipitation (ChIP) has been used in many 
systems and for many DNA-binding proteins to understand the binding dynamics of a 
factor, as well as to identify the direct target genes that they regulate. Even though 
Smad2 is one of the most important transcription factors in early vertebrate 
development, few studies addressed the binding patterns of this factor, partly because 
of the relative difficulty of the pull down, stemming from the fact that Smad2 doesn’t 
bind to DNA directly. Six papers employing Smad2 ChIP have so far been published. 
Three of these performed ChIP in human or mouse cell culture (Brown et al., 2011; 
Fei et al., 2010; Kim et al., 2011), and the most recent one in Xenopus embryo (Chiu 
et al., 2014).  
Two previous studies (Liu et al., 2011; Nelson et al., 2014) described 
Smad2 ChIP results in zebrafish embryos. The first of those two studies used 
untreated early gastrula (high-sphere stage) embryos for their Smad2 pulldown, and 
anti-Smad2/3 (3102, Cell Signaling Technology) antibody. For the analysis of the 
pulled-down DNA, they used The Zebrafish Promoter Genome ChIP-on-chip 
! DL!
Microarray Set (Agilent Technologies). This oligonucleotide-based promoter array set 
covers 9kb upstream of and 3kb downstream of the transcription start sites of 11,512 
zebrafish genes. Since many developmental enhancers can be as far as several 
hundred kilobases from the transcription start site of gene that they regulate, this 
study was unable to discover many Smad2 binding sites. The researchers found 556 
Smad2 peaks, and only 14 of those were close to well-known Nodal regulated genes.  
The second study in 2014 used 5000 wild type zebrafish embryos at 
early gastrula stage (high stage) and Smad2 monoclonal antibody (clone 31H15L4; 
Thermo Fisher Scientific) for their pulldown. High-throughput DNA sequencing was 
used to analyze the acquired DNA. This group was successful in obtaining good 
genome coverage, and identifying a large number of Smad2 binding sites in proximity 
to known Nodal target genes. Using RNA-Seq, they also identified a number of new 
potential Nodal signaling targets. To identify Smad2 peaks with high level of 
certainty, it is very useful to know where its co-factors (FoxH1, Mixer, eomesA) bind 
in the genome. The Wardle lab performed eomesA ChIP-Seq as well as Smad2 ChIP-
Seq (Nelson et al., 2014), but no FoxH1 ChIP-Seq data in zebrafish embryos has been 
previously published. The dataset that I acquired (see Chapter II) is therefore 
important for the deeper understanding of how Smad2 binding in response to Nodal 
signaling is controlled during vertebrate embryonic development.  
The caveat of previously published Smad2 binding data in zebrafish is 
that both groups used untreated, wild type embryos for their work. Wild-type embryos 
are a mixture of cells with a very high number of cells not experiencing any Nodal 
signaling, a few that are exposed to low levels of it, and very few exposed to high 
Nodal levels. We can therefore suppose that many binding sites that are only occupied 
when a cell is exposed to very high signal levels would be overlooked with this setup. 
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Another concern is that the stage that both groups selected (high-sphere and high 
stage, respectively) happens very early in the development, at the very onset of Nodal 
signaling. Thus, it is possible that enhancers that are occupied by Smad2 only in the 
presence of high levels of Nodal and/or after long exposure to the signal would not be 
detected. I carried out Smad2 pull-down experiments in embryos injected with squint 
mRNA to find out the regulatory elements that are bound at high Nodal signaling 
levels, and analyzed their responsiveness to Nodal signaling.  
 
 
RESULTS 
Identification of Smad2-bound loci and co-bound transcription factor candidates 
To activate Nodal signaling uniformly, I used embryos that were 
injected with 5pg of squint mRNA at one-cell stage. For comparison, I also performed 
ChIP-Seq in embryos treated with a Nodal signaling inhibitor. I also chose to study a 
later developmental stage (dome) than the ones used in the two previously published 
papers. The later developmental stage and the fact that the extracellular space in the 
embryos is flooded with Nodal signaling molecules from the moment squint mRNA 
starts being translated, means that genes requiring long exposure to the signal will be 
activated by the time the embryos are collected.  
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Figure 3.1 (continued on the next page) 
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Figure 3.1 (continued) 
 
 
Figure 3.1 
Smad2 transcription factor binds to regulatory elements in a Nodal-dependent 
manner 
For each of the shown Nodal target genes (lhx1a, gsc, ntla, lft2) Smad2 and FoxH1 
ChIP-Seq tracks are shown.  
Tracks from top to bottom: overlay of Smad2 ChIP-Seq track from squint injected 
(red line) and Nodal inhibitor treated (blue line) embryos; peaks called by MACS 
program in squint injected sample; FoxH1 ChIP-Seq track from squint injected 
embryos; peaks called by MACS program in squint injected FoxH1 sample; genomic 
track.  
 
ChIP analysis identified 1041 peaks Smad2 binding peaks in squint 
mRNA-injected embryos [Fig.3.1]. I identified 614 genes with TSS no further than 
20kb away from a Smad2 peak. Gene Ontology analysis of these genes singled out 
these classes of genes as overrepresented: dorsal/ventral pattern formation; 
anterior/posterior axis specification; mesendoderm morphogenesis and cell migration; 
liver, digestive tract, pancreas, floor plate, and neural tube development; left/right 
asymmetry determination. Previously studied Nodal-regulated genes in vertebrates 
also regulate these classes of genes.   
There was a strong overlap between Smad2 and FoxH1 binding sites 
[Fig.3.1], 58% of Smad2 peaks overlapped with a FoxH1 peak. I extracted genomic 
DNA sequence of Smad2 peaks and used XXMOTIF online tool to look for 
transcription factor binding elements (BEs). Consensus sequences for the following 
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transcription factors were found: FoxH1, Homeobox and Oct-family proteins, 
EomesA, and Smad2/3 [Fig.3.2]. FoxH1 transcription factor has long been known to 
be necessary for Nodal signaling (Pogoda et al., 2000; Weisberg et al., 1998) and so 
have homeobox factors Mixer and Mezzo (Kunwar et al., 2003; Poulain and Lepage, 
2002). Oct-family proteins play an important role in the regulation of pluripotency in 
undifferentiated cells, and Oct1 transcription factor in particular had been shown to 
directly interact with Smad2 protein (Liu et al., 2011). EomesA is another 
transcription factor that has been implicated in this pathway in several model 
organisms, including zebrafish (Nelson et al., 2014). One study, using a dominant 
negative version of EomesA transcription factor in zebrafish, suggested that EomesA 
together with FoxH1 are the two main factors needed for the interpretation of Nodal 
signaling in embryonic cells (Slagle et al., 2011). 
One of the particularly interesting motifs I identified is that of Osr1 
transcription factor [Fig.3.2]. Odd skipped related 1 (Osr1) is a zinc finger 
transcription factor, homolog of the Drosophila pair-rule gene odd. Research in 
vertebrates showed that is expressed in a distinctive way in the intermediate 
mesoderm, and plays an essential role in kidney formation in mice and zebrafish 
(Mudumana et al., 2008; Mugford et al., 2008). Loss of function studies in zebrafish 
revealed an additional role for osr1 in endoderm patterning, as loss of osr1 caused an 
increase in the number of cells expressing endoderm markers sox17 and foxa2 
(Mudumana et al., 2008). Further studies showed that it is induced in mesendoderm 
by Nodal signaling, and that Osr1 activity is required to limit the number of sox32 
expressing endoderm cells (Terashima et al., 2014). Taken together, these results 
suggest that Osr1 is a negative regulator of endoderm-specific Nodal signaling. The 
mechanism of its inhibitory effect has not been studied, and our finding that Osr1 
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binding element is found in almost a quarter of Smad2 binding sites suggests that the 
inhibition might be achieved by competition for the binding sites. I looked for the 
genes that Smad2 peaks with an Osr1 binding element were close to, and identified 61 
of those, one of which is foxa3, a definitive endoderm marker (Grapin-Botton, 2008). 
Gene Ontology analysis of these 61 genes showed that there was an enrichment of 
endoderm specification genes (p-value of 1.60E-02), but not mesodermal ones (Mi et 
al., 2013).   
   
 
Figure 3.2 
Binding motifs enriched in genomic sequences bound by Smad2 in Squint-injected 
embryos 
FoxH1, EomesA, Smad2/3, Osr1, homeobox family and Oct-family binding 
sequences were enriched in the analyzed genomic sequences. 
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Identified regulatory elements can drive gene expression in a Nodal-responsive 
manner 
To test whether the Smad2 binding loci are in fact functional enhancer 
elements, I created reporter constructs where these elements were driving the 
expression of eGFP and used them in transient transgenic fish experiments. I built 
reporter constructs, in which the tested DNA element was cloned in front of a 
minimal promoter followed by the eGFP transcript [Fig.3.3.A]. I used Zebrafish 
Enhancer Detector (ZED) vector that was designed specifically for testing regulatory 
elements in zebrafish embryos (Bessa et al., 2009). It contains a built-in minimal 
promoter for eGFP, which is unable to drive expression on its own, and a positive 
transgenic marker: RFP protein driven by cardiac actin promoter. This Tol2 
transposon-based vector also contains insulator sequences to shield the minimal 
promoter from position effects (Bessa et al., 2009). I tested putative enhancers from 5 
different known Nodal targets, in each case cloning an approximately 500bp DNA 
stretch centered on the Smad2 binding locus. The enhancers of lhx1a, lft1, ntla, gsc 
and bhik were tested in this manner. In all cases, this setup led to the expression of 
eGFP in the embryonic margin area at shield stage, which is where Nodal signaling is 
active in wild-type embryos [Fig.3.3.B-C].  
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Figure 3.3 (continued on the next page) 
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Figure 3.3 (continued) 
Smad2-bound putative enhancer elements drive gene expression in the embryo 
margin zone  
A) Zebrafish Enhancer Detection (ZED) vector was used to test enhancer elements, as 
published in (Bessa et al., 2009). Gateway system was used to clone various putative 
enhancer elements into this vector.  
B) Smad2-bound enhancer element 6kb upstream from the gsc gene TSS was used to 
drive eGFP expression in shield stage embryos. The sequence of the element shows 
consensus binding sequences of FoxH1 (cyan) and Smad2/3 (magenta). The picture 
on the left shows the observed eGFP expression pattern, while the picture on the right 
shows the expression pattern of the gsc gene visualized by in situ (from (Thisse and 
Thisse, 2008)). 
C) The sequence of the enhancer element in the first intron of lhx1a gene, the 
observed eGFP expression driven by it and in situ pictures of lhx1a expression pattern 
(Thisse and Thisse, 2008) are shown.  
 
 
To test whether the expression driven by these enhancers will be 
responsive to Nodal signaling levels, I treated the transfected embryos with Nodal-
inhibiting drug, or injected them with 5pg of squint mRNA at one-cell stage. I tested 
enhancer elements from ntla and lhx1a genes, and this test showed that the 
information contained in that stretch of DNA is indeed sufficient to make gene 
expression Nodal-responsive [Fig.3.4].  
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Figure 3.4  
Expression driven by the regulatory element of ntla gene is responsive to Nodal 
signaling levels 
A) Smad2-bound enhancer element 2kb upstream from the ntla gene TSS was used to 
drive eGFP expression in shield stage embryos. The sequence of the element shows 
consensus binding sequences of FoxH1 (cyan) and Smad2/3 (magenta).  
B) From left to right, eGFP expression is shown in embryos injected with 5pg squint 
mRNA, untreated, or treated with Nodal drug inhibitor. Top row: bright-field view; 
bottom row: image taken by fluorescence microscope.   
 
After exposure to low and high levels of Nodal signaling Smad2 binds near 
different groups of genes  
Since the results of the first paper that published Smad2 ChIP in 
zebrafish showed very limited results (Liu et al., 2011), I directly compared my 
results to the paper published by the Wardle group in 2014 (Nelson et al., 2014). In 
this work they identified 897 Smad2 peaks and 561 genes within 20kb of these. My 
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ChIP-Seq analysis identified 1041 Smad2 peaks and 614 genes with 20kb. These two 
lists had 145 genes in common between them.   
Transcription factor binding on its own is not sufficient to identify real 
targets of that factor, and gene expression data has to be used as additional evidence. 
To make sure that I have few false negatives, the list of potential Nodal targets I used 
was as comprehensive as possible. This list included 235 genes that were identified as 
Nodal-regulated in previously published literature (Bennett et al., 2007; Nelson et al., 
2014), as well as 330 genes that were found to be Nodal-responsive using RNA-Seq 
data acquired in our lab [unpublished, Andrea Pauli]. Dr. Pauli collected gene 
expression data in dome stage zebrafish embryos that were unperturbed, injected with 
5pg of squint mRNA, or were mutant for the oep gene (MZoep).  I chose the genes 
that, when compared to untreated embryos, were either upregulated by a factor of 1.5 
in squint injected ones, or downregulated by a factor of 1.5 in MZoep embryos.  
These two groups of Nodal targets genes had 83 targets in common, resulting in a list 
of 482 genes that change their expression in response to Nodal signaling, because of 
either direct or indirect effect on their transcription.  
A gene was called a bona fide Nodal target if it both changed 
expression in response to a change in Nodal signaling levels, and had a Smad2 peak 
within 20kb of their TSS. There were 88 such genes based on the Wardle Smad2 
dataset, and 111 based on mine, with 56 shared genes [Fig.3.5]. 
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Figure 3.5 
Overlap between Smad2-proximal genes identified based on the Wardle group data, 
my ChIP-Seq data, and Nodal-responsive genes 
A large number of genes overlapped between these three groups. Nodal-responsive 
genes that do not have a Smad2 peaks in either of the ChIP-Seq datasets are probably 
not direct Nodal target genes. Of special interest are the two groups of genes that are 
Nodal responsive but have a proximal Smad2 peak only in one dataset or the other.  
 
 
Table 3.1: 
Previously unpublished Nodal target genes 
 
acot11a ptf1a 
cpn1 rasd1 
dhrs3b rfx2 
dhrs9 ripply1 
ednraa s1pr5a 
fam162a sall3b 
golim4b samm50l 
her6 six4b 
her9 slc13a4 
lmo1 slc25a22 
mapk11 smtnl 
mnx1 tcf3b 
pcdh18a uchl5 
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Our results therefore identified 55 direct Nodal target genes that were 
not picked up by the previously published research. Of those 55 genes, 29 were 
previously described as responsive to the levels of Nodal signaling (directly or 
indirectly), while 26 are previously unpublished novel target genes [Table 3.1]. Based 
on Gene Ontology analysis these genes were enriched for DNA-binding transcription 
factors, as well as genes involved in early developmental processes and anatomical 
structure development.  
 
 
DISCUSSION  
Smad2 is a factor that is indispensible to Nodal signaling transduction. 
Since its binding to DNA is considered to be the activating signal for target gene 
expression, we must understand its recruitment process to learn how cellular response 
to Nodal is regulated. This study gets us one step closer to this goal.  
Understanding where and when Smad2 binds in zebrafish genome is of 
particular interest for developmental biology. It is more representative of actual 
embryonic development than studies done in cell culture, as we observe the regulation 
of signaling in its native context. Smad2 binding data can also be related to the in vivo 
Smad2 nuclear accumulation data to build better models of concentration-dependent 
target gene induction (Dubrulle et al., 2015).  
Our study identified Smad2 binding peaks in embryos overexpressing 
Nodal signal Squint, and we found 55 Nodal-regulated genes not found in the 
previously published datasets (Liu et al., 2011; Nelson et al., 2014). To find out 
whether this difference is meaningful, one could compare the expression driven by the 
regulatory regions of some of these 55 genes and some of the genes that were only 
! ??!
identified in the Wardle group dataset. These regulatory regions could then also be 
tested for Nodal-responsiveness in zebrafish embryos. If the information in the 
sequence of these DNA elements is sufficient to dictate Smad2-binding conditions, 
we expect Smad2 to bind to the elements in the first group only when the cell is 
exposed to high Nodal levels. These enhancers should then drive expression only 
close to the margin of the embryo and in the shield region. Enhancers of genes that 
didn’t have Smad2 binding near their TSS in our data, but had in the Wardle group 
data, should then drive expression further away from the margin.  
Identifying the different factors that can bind to these elements could 
provide a lot of information on how gene expression threshold is determined. While it 
is possible that some of the threshold-determining information is contained in the 
promoter region rather than in the enhancer (Dubrulle et al., 2015), understanding 
Smad2 binding would undoubtedly provide us with some answers to threshold 
control. Another attractive approach to understating differential Smad2 binding to 
regulatory elements would be building synthetic enhancer elements. We could 
combine the consensus binding sequences of Smad2/3, FoxH1, EomesA, Oct1 and 
others in different numbers and positions to see how it affects expression. 
We also identified 26 genes that were not previously shown to be 
Nodal-regulated. This group of genes showed enrichment for DNA-binding 
transcription factors and it brings us closer to building the gene regulatory network of 
vertebrate development.  
Attempts have been made to find a small group (FoxH1 and Mixer; 
FoxH1 and eomesA) of transcription factors that are responsible for all Smad2-
dependent Nodal signaling transduction in zebrafish, but a convincing result has yet to 
be reached (Kunwar et al., 2003; Slagle et al., 2011). It is likely that more than two 
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co-transcription factors have to be lost to faithfully mimic loss of Nodal signaling 
phenotype. A number of other factors, such as Mezzo, p53, Gata5 have also been 
shown to interact with Smad2 (Cordenonsi et al., 2003; Poulain and Lepage, 2002; 
Reiter et al., 2001). We also found the consensus binding sequence of Oct-family 
proteins in more than half of the Smad2 binding regions and we identified Osr1 as 
another potentially important regulator. Our study brings us one step closer to a 
comprehensive list of Smad2-interacting transcription factors. 
I tested short DNA elements centered on a Smad2 binding peak for 
their ability to drive gene expression in a Nodal-dependent manner in transient 
transgenic fish. It would be very informative to do further experiments in stable 
transgenics, to find the precise region of their expression in wild-type embryos and 
embryos injected with various levels of squint mRNA. Another important experiment 
would be observing the behavior of these enhancers in FoxH1 mutant background.  
Any residual Nodal-dependent expression in such background should be the result of 
other Smad2 recruiting factors binding to it.  
To sum up, the results I present in this chapter expand the repertoire of 
known Nodal target genes, identify an important group of Smad2-binding regulatory 
elements and test their responsiveness to Nodal signaling.  
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MATERIALS AND METHODS 
 
Chromatin Immunoprecipitation (ChIP) 
Zebrafish TLAB embryos were dechorionated with pronase at one-cell stage, and 
300-500 embryos at dome stage were used for each experiment, as previously 
described (see Chapter II). Anti-Smad2 antibody (Invitrogen 51-1300) was used for 
the pull-down.   
 
ChIP-qPCR 
ChIP was done using shield stage embryos. The eluted DNA was analyzed using 
SYBR® Green I (BioRad) and DNA Engine Opticon System (MJ Research) with 
technical duplicates. ChIP enrichment was normalized to input, and shown as % 
input.  
 
ChIP-Seq 
ChIP with anti-Smad2 antibody was performed as described. Embryos were 
untreated, incubated at 1-cell stage with 10mM Nodal inhibitor drug SB-505124 
(DaCosta Byfield et al., 2004) (S4696 SIGMA), or injected at 1-cell stage with 5pg of 
squint mRNA. Sample DNA was sequenced on Illumina Hi-Seq platform. ChIP-seq 
reads were mapped using Bowtie (v.0.12.9) (Langmead, 2010); peaks were called 
using MACS (v.2.0.10) (Zhang et al., 2008). De novo motif analyses used XXMOTIF 
(Hartmann et al., 2013). JASPAR public database was used to find candidate proteins. 
GO analyses were performed using PANTHER (protein annotation through 
evolutionary relationship) classification system (Mi et al., 2013). 
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RNA-Seq  
Sample preparation was done as previously described (see Chapter II). Embryos were 
untreated, incubated at 1-cell stage with 10mM Nodal inhibitor drug SB-505124 
(DaCosta Byfield et al., 2004) (S4696 SIGMA), or injected at 1-cell stage with 5pg of 
squint mRNA. Samples were sequenced on Illumina Hi-Seq platform, and aligned to 
Danio rerio genome Zv9 assembly. Differential gene expression analysis of RNA-Seq 
data was performed using TopHat (v. 1.3.3) (Trapnell et al., 2009) and Cuffdiff (v. 
1.3.0) (Trapnell et al., 2012). GO analyses were performed using PANTHER (protein 
annotation through evolutionary relationship) classification system (Mi et al., 2013).  
 
Transient transgenic zebrafish generation 
Transposase (Kawakami et al., 2004) cDNA containing vector was linearized with 
NotI restriction enzyme and mRNA was transcribed using Sp6 RNA polymerase. The 
Tol2-based method of transgenesis (Kawakami et al., 2004) was used. At one-cell 
stage, each embryos was injected with a 1nl mixture containing 50 ng/ul of 
transposase mRNA and 40 ng/ul of purified vector DNA. Embryos were incubated 
until shield stage and then imaged.  
 
Nodal induction dynamics (from (Dubrulle et al., 2015)) 
Wild-type embryos were first injected at the one-cell stage with 1 nl of cyclops and 
squint MOs mixture (at 0.2 mM and 4 µg/µl, respectively) to inhibit endogenous 
Nodal signals. Morphants were further injected with 0.5–1.5 nl of recombinant mouse 
Nodal protein (rmNodal, R&D Systems, Minneapolis, MN) at different 
concentrations in the extracellular space at 4hpf (sphere stage). For NanoString 
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analysis total RNA from 5 to 10 embryos for each data point was extracted using the 
RNAeasy mini kit (Qiagen, The Netherlands) and 100ng of input RNA was processed 
through the nCounter assay using standard protocols (NanoString Technologies, 
Seattle, WA) (Kulkarni, 2011).  
 
In situ hybridization 
In situ hybridization on whole mount embryos was carried out using standard 
methods (Thisse and Thisse, 2008). Embryos were fixed in 4% formaldehyde 
overnight, and then dehydrated, rehydrated, and stained. Following staining, embryos 
were cleared in benzyl benzoate/benzyl alcohol (2:1 vol/vol) and imaged.  
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CHAPTER IV  
Analysis of the relationship between Nodal target gene expression and histone 
modifications 
 
ABSTRACT 
While is has been demonstrated in many systems that chromatin marks are strongly 
associated with the transcriptional status of genes, many questions in this area still 
remain unanswered. In this chapter I describe the study of the interaction between 
Nodal signaling in early zebrafish development and chromatin marks. I found that 
exposure of embryonic cells to high levels of Nodal is associated with low levels of 
H3K27me3 and high levels of H3K4me3 marks on Nodal target genes, relative to 
those in unexposed cells. One of the most important questions in the field of 
epigenetics is the causal relationship between gene transcription and histone marks, as 
well as the chromatin-dependent mechanisms by which transcription factors modulate 
target gene expression. Here I describe a Cas9-based system that we used to change 
H3K27me3 levels in a targeted manner, and tested it in a developing embryo on a 
Nodal-responsive fgf8a gene. Our results suggest that reduction of H3K27me3 mark 
on its own is not sufficient to affect the expression of this gene, and additional 
mechanisms are involved in target gene activation by Smad2.  
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INTRODUCTION 
Nodal signaling pathway drives the differentiation of pluripotent cells 
toward mesendodermal lineage. It has not, however, been extensively investigated 
how this signaling network cooperates with chromatin state during embryonic 
development. Zebrafish embryonic genome is inactive until maternal-zygotic 
transition, when transcription is initiated (Schier, 2007). After genome activation 
many genes acquire either an H3K4me3 or H3K27me3 chromatin mark at their 
promoters, which are associated with active and silenced genes, respectively 
(Vastenhouw et al., 2010). Some developmentally important genes, including a 
number of Nodal targets, are marked by bivalent chromatin domains, with both 
H3K4me3 and H3K27me3 marks present at their promoter. In embryonic stem cells 
these bivalent domains have been hypothesized to ‘poise’ developmental genes for 
rapid activation (Bernstein et al., 2006) and then resolve into either repressive 
(H3K27me3) or active (H3K4me3) state upon differentiation (Mikkelsen et al., 2007; 
Pan et al., 2007).  
A study in human embryonic stem cells (hESCs) examined how 
Nodal signaling interacts with and affects particular chromatin states during 
endoderm commitment (Kim et al., 2011). This study showed that exposure of hESCs 
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to Nodal signaling leads to the activation of Nodal target genes and the concomitant 
reduction of H3K27me3 and increase of H3K4me3 marks at their promoters, in a 
manner highly correlated with SMAD2/3 binding. A mechanism for this process has 
been proposed: it has been demonstrated that SMAD2/3 was capable of recruiting the 
histone demethylase, JMJD3, to the NODAL promoter in mouse ESCs, causing the 
loss of the repressive mark H3K27me3 (Dahle et al., 2010). This study suggested that 
Nodal signaling induces target gene expression primarily through de-repression 
caused by the removal of H3K27me3 mark. 
It is not known how H3K4me3 and H3K27me3 marks on Nodal target 
genes behave in vivo when undifferentiated cells are exposed to Nodal signaling. To 
address this question, we combined whole-genome H3K27me3 and H3K4me3 ChIP-
Seq and targeted chromatin modification at the Nodal-responsive gene fgf8a in 
zebrafish embryos. We found that exposure to high levels of Nodal is associated with 
low levels of H3K27me3 and high levels of H3K4me3 marks on Nodal target genes. 
Our results also suggest that reduced H3K27me3 is associated with but not sufficient 
for Nodal target gene activation. 
 
 
RESULTS 
Nodal signaling increases H3K4me3 and reduces H3K27me3 marks at target 
genes  
To determine the H3K4me3 and H3K27me3 states of Nodal-regulated 
genes, we employed genome-wide ChIP-Seq in zebrafish embryos at shield stage (6 
hpf). In wild-type embryos Nodal signaling at this stage is fully active and 
gastrulation has begun. Under normal conditions only a subset of cells close to the 
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margin of the embryo is exposed to Nodal signaling, creating a heterogeneous cell 
population. To compare homogeneous cell populations, we used embryos in which 
Nodal signals were either expressed ubiquitously or globally repressed. Ubiquitous 
expression was achieved by injecting 5 pg of squint mRNA at one-cell stage 
(Feldman et al., 1998). To achieve global inhibition of the signaling, a drug that 
specifically blocks Nodal receptors, SB-505124 (DaCosta Byfield et al., 2004), was 
added to the medium in which embryos were incubated. In order to identify regions 
that exhibit a change in H3K27me3 or H3K4me3 levels in response to Nodal 
signaling, we used MACS peak-calling program on the acquired ChIP-Seq data 
(Zhang et al., 2008b). 
H3K4me3 and H3K27me3 marks on important developmental genes 
are subject to extensive changes during early development. As we wanted to 
understand the dynamics of these marks on Nodal-regulated genes in particular, we 
focused on a short list of genes that were defined as direct targets using stringent 
criteria. A gene had to exhibit increased Nodal-induced expression visible by in situ 
hybridization, could be induced by Nodal in the presence of translation-blocking 
cycloheximide, and be bound by Smad2 and FoxH1 transcription factors (Dubrulle et 
al., 2015). Not all genes from this list are expressed at shield stage, so we isolated and 
sequenced mRNA from shield stage embryos injected with 5 pg of squint mRNA and 
MZoep mutants. Based on the collected RNA-Seq data, we focused on 24 genes that 
exhibited more than a threefold change in expression between these two conditions at 
shield stage. 
We then looked at the levels of H3K4me3 and H3K27me3 mark at the 
TSS of these genes at shield stage. Of these 24 genes, 18 exhibited higher levels of 
H3K4me3 mark and 12 exhibited lower levels of H3K27me3 mark in response to 
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Nodal signaling, with 10 genes displaying a change in both marks [Fig.4.1]. In total 
among 16130 RefSeq genes we looked at, 344 showed a change in H3K4me3 levels, 
and 45 in H3K27me3 levels. In some cases, Nodal-regulated genes completely lacked 
H3K27me3 marks in their promoter regions in the squint-injected sample. For 
example, the Nodal target gene fgf8a was associated with very high H3K4me3 and 
low H3K27me3 levels in embryos injected with squint mRNA [Fig.4.1]. These results 
indicate that Nodal signaling increases H3K4me3 and reduces H3K27me3 mark at the 
majority of its direct targets. 
 
A. ntla                 
 
B. lhx1a                       
 
 
C. b-actin2     
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Figure 4.1 (continued) 
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Figure 4.1 
Genome-wide chromatin modification changes in zebrafish embryo in response to 
Nodal signaling 
Examples of chromatin mark change on different genes in response to Nodal 
signaling as demonstrated by ChIP-Seq at shield stage. Peak tracks show the peaks 
called by MACS2 using one treatment as the tag track, and the opposite treatment as 
the control track. 
A - B) ntla and lhx1a are well-studied Nodal signaling targets. In response to Nodal 
signaling (red line) both exhibit a higher level of H3K4me3 and lower level of 
H3K27me3.  
C) b-actin2 is a housekeeping gene, which is not affected by Nodal levels. Under each 
of the two conditions it has high H3K4me3 levels and no H3K27me3 mark.   
D) hox11a, hox12a and hox13a genes are silenced at shield stage and have only 
H3K27m3 mark. 
E) sox3 is a gene that is inhibited by Nodal signaling. The levels of both histone 
marks behave in manner opposite to the positively regulated Nodal target genes. 
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Synthetic activation of a Nodal target gene 
In order to study the interplay between chromatin modifications and 
gene expression in more detail, we focused on the Nodal-regulated gene fgf8a, as this 
gene was a particularly good candidate for our study. fgf8a has a very strong 
H3K4me3 peak and almost no H3K27me3 in squint injected embryos, and the reverse 
of it in embryos treated with a Nodal signaling inhibitor [Fig.4.2.A].  
We first asked whether the changes in H3K4me3 and H3K27me3 
marks are specific to Nodal-induced overactivation of the gene or whether they are a 
property of fgf8a activation in general. To distinguish between these possibilities, we 
targeted a fusion construct of catalytically dead Cas9 (dCas9) with the VP64 
activation domain to the promoter region of fgf8a [Fig.4.2.A and B]. Targeting 
dCas9-VP64 to two gRNA binding sites upstream of the transcription start site 
increased fgf8a expression [Fig4.2.C].  
 
 
 
Figure 4.2 (continued on the next page) 
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Figure 4.2 (continued) 
Induced gene expression using targeted dCas9-VP64 localization 
(A) ChIP-Seq tracks of H3K27me3 and H3K4me3 histone marks on fgf8a promoter 
in wild type shield stage zebrafish embryos. Insert: qPCR amplicons used to analyze 
H3K27me3 and H3K4me3 marks by ChIP-qPCR, tagged by the distance from fgf8a 
transcription start site (TSS) in kbs.   
(B) Positions of the two gRNAs used for dCas9-VP64 targeting to the fgf8a promoter. 
(C) dCas9-VP64 increases fgf8a expression compared to uninjected control. In fish 
strain with a SNP mismatch (dCas9-VP64 SNP mismatch) in its genome, no increase 
is observed. 
 
Targeting dCas9-VP64 to the fgf8a transcription start site also reduced 
H3K27me3 and increased H3K4me3 marks [Fig.4.3]. The effects on fgf8a expression 
and H3K4 and H3K27 methylation were completely abrogated [Fig.4.2.C] when 
dCas9-VP64 was targeted to an fgf8a allele that had a single mismatch within the 
target site of one of the gRNAs. These results showcase the use of naturally occurring 
SNPs as experimental controls for Cas9-based tools and reveal that a synthetic 
activator can induce transcription and changes in H3K4 and H3K27 methylation at a 
Nodal target gene. 
 
Figure 4.3 
Changes in chromatin marks induced by targeted dCas9-VP64 localization 
ChIP-qPCR of H3K27me3 (A) and H3K4me3 (B) mark on fgf8a gene shows a 
decrease in the levels of the mark of the former and increase in the levels of the latter 
following dCas9-VP64 injection. No change in the levels of either mark is observed 
in the fish strain with a SNP mismatch. 
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Targeted reduction of H3K27me3 levels  
Cell culture studies of a Nodal target gene suggested that reduction of 
H3K27me3 marks might be sufficient for gene activation (Dahle et al., 2010). To test 
if this hypothesis holds true in vivo, we wished to specifically reduce H3K27me3 at 
the fgf8a locus. Standard approaches, such as histone modifier mutants, affect 
chromatin and gene expression globally, making it impossible to conclusively test the 
role of a specific chromatin mark at individual genes. For a locus-specific effect, 
sequence-specific DNA-binding domains or Cas9-based fusions can instead be used 
to locally change DNA methylation or histone marks (De Groote et al., 2012; Hilton 
et al., 2015; Kearns et al., 2015; Keung et al., 2014; Mendenhall et al., 2013; Rush et 
al., 2009). We therefore decided to recruit the H3K27me3 demethylase domain of 
UTX fused to dCas9 (dCas9-UTX) to the fgf8a locus [Fig.4.4.A]. To control for 
changes in H3K27me3 not due to UTX catalytic activity, we also generated a 
catalytically inactive version of the protein (dCas9-UTX-H1146A). Six gRNAs were 
designed to target the H3K27me3-containing region of fgf8a [Fig.4.4.A]. dCas9-
UTX, but not dCas9-UTX-H1146A, reduced H3K27me3 across the fgf8a gene 
[Fig.4.4.B]. No change was detected for H3K4me3 levels [Fig.4.4.C] and nucleosome 
occupancy at the fgf8a locus, and H3K4me3 and H3K27me3 marks at other Nodal 
target genes were not altered. These results demonstrate that dCas9-UTX can reduce 
H3K27me3 levels in vivo at a locus of choice.  
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Figure 4.4  
H3K7me3 mark reduction by dCas9-UTX  
(A) Positions of the six gRNAs used for dCas9-UTX targeting to fgf8a. 
ChIP-qPCR of H3K27me3 (B) and H3K4me3 (C) mark on fgf8a gene shows a 
decrease in levels of H3K27me3, but no change of H3K4me3. No change in the levels 
of either mark in observed with the catalytically inactive version of UTX: dCas9-
UTX-H1146A. 
 
To determine whether the six gRNAs contributed differentially to 
H3K27me3 reduction, we analyzed subsets of the guide RNAs. gRNAs fgf8-g3 and 
fgf8-g4 were tested individually, and three different pairs of gRNAs were analyzed 
(fgf8-g1/g2, fgf8-g5/g6, fgf8-g2/g5) [Fig.4.5.A]. None of these subsets reduced the 
H3K27me3 mark, while a combination of 4 gRNAs (fgf8-g1/g2/g5/g6) reduced 
H3K27me3 to similar levels as all six guide RNAs [Fig.4.5.B]. The changes in 
H3K27me3 levels achieved by dCas9-UTX with either 4 or 6 gRNAs were similar to 
those achieved by dCas9-VP64. These results show that combinations of 4 gRNAs are 
sufficient to target dCas9-UTX to a specific locus and induce the local reduction of 
H3K27me3. 
! MG!
 
 
Figure 4.5  
Combinations of 4 gRNAs are sufficient for H3K7me3 mark reduction  
 (A) Different gRNA combinations were coinjected with dCas9-UTX: 1 gRNA only 
(either fgf8-g3 or fgf8-g4); 2 gRNAs together ((fgf8-g1/g2) or (fgf8-g5/g6) or (fgf8-
g2/g5)); 4 gRNAs together (fgf8-g1/g2/g5/g6). 
(B) ChIP-qPCR measurement of H3K27me3 mark on fgf8a gene and 3 negative 
control regions (lhx1a, pitx2, lft1) upon the injection of different combinations of 
gRNAs. Combination of 4 gRNAs was equally as effective as 6 gRNAs, while no 
other combination changed H3K27me3 levels.  
 
 
 
 
 
! MD!
Reduction of H3K27me3 is not sufficient to increase target gene expression  
We analyzed fgf8a mRNA levels in embryos injected with 4 gRNAs 
and the dCas9-UTX fusion to determine whether reduction of H3K27me3 levels at 
the fgf8a locus affects gene expression. As a control, we injected a dCas9-sfGFP 
fusion that does not affect H3K27me3 levels. No difference in expression was 
detected either by RT-qPCR or in situ hybridization [Fig.4.6.A and B], suggesting 
that reduction in H3K27me3 levels alone is not sufficient to cause an increase in the 
expression of this Nodal target gene.   
 
 
Figure 4.6  
fgf8a gene expression levels following the injection of dCas9-sfGFP or dCas9-UTX 
construct with 4 gRNAs  
(A) RT-qPCR measurements of fgf8a expression with the injection of dCas9-UTX or 
dCas9-sfGFP showed no significant difference.  
(B) Whole mount in situ hybridization of the injected embryos at shield stage showed 
no increased or ectopic expression of fgf8a.  
(C) Response of fgf8a to Nodal overexpression, as achieved by squint mRNA 
injection, was similar. 
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To test whether the responsiveness of fgf8a to Nodal signaling might 
be affected by reduction of H3K27me3 levels, Nodal signaling was increased by 
injection of different amounts of squint mRNA or decreased by addition of the Nodal 
receptor inhibitor SB-505124 in the presence of dCas9-UTX or dCas9-sfGFP fusions. 
The levels of expression, as measured by RT-qPCR, were in all cases similar between 
the embryos injected with dCas9-UTX and dCas9-sfGFP constructs [Fig.4.6.C]. 
These results suggest that H3K27me3 reduction is not sufficient to render a target 
gene more responsive to Nodal signaling. 
 
 
DISCUSSION 
Our study of histone marks at Nodal target genes generates tools and 
datasets for the analyses of chromatin modifications during early embryogenesis and 
indicates that the reduction of H3K27me3 levels is associated with but not sufficient 
for gene activation. ChIP-seq analyses reveal that Nodal signaling affects the 
chromatin landscape of its target genes: the repressive H3K27me3 mark decreases on 
target gene promoters, while the mark associated with active genes, H3K4me3, 
increases. While we find that such changes accompany both Nodal-induced and 
dCas9-VP64-induced gene expression, simply reducing H3K27me3 levels by dCas9-
UTX is not sufficient for gene activation.  
Both short and long-term effects of Nodal signaling on chromatin have 
been previously studied in human ES cells (hESCs). A recent study showed that a 
short (2-8 hours) treatment of hESCs with Nodal signaling inhibitor led to a rapid 
decrease in H3K4me3 levels, but did not affect H3K27me3 levels on any of the target 
genes (Bertero et al., 2015). This result suggests a model where Nodal signaling is 
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responsible for the deposition/maintenance of the activating mark, but does not 
directly affect the levels of H3K27me3. In contrast, the results of the ChIP-Seq 
experiments we performed show that in a developing embryo the levels of both of 
these marks are affected by Nodal signaling. Another study in hESCs showed that 
endodermal cells derived after a 5-day treatment with Activin exhibited a marked 
changed in the levels of both H3K4me3 and H3K27me3 histone marks (Kim et al., 
2011). Similar results were observed in mouse ES cells, and suggested that the key 
role of Nodal signaling was to recruit H3K27me3 demethylases to target genes to de-
repress gene expression (Dahle et al., 2010). In this scenario, the default state of 
Nodal target gene is to be active unless repressed by H3K27me3 marks. Our results, 
however, show that local reduction of H3K27me3 levels by dCas9-UTX is not 
sufficient to upregulate fgf8a expression in vivo or to increase its responsiveness to 
activating signals. This finding suggests that Nodal signaling activates its target genes 
by regulating more than the deposition and removal of H3K27me3 marks. Although it 
is conceivable that other Nodal target genes respond differently or that removal of 
additional repressive marks would activate fgf8a, we favor a model in which Nodal 
signaling not only de-represses target genes but also actively switches them on. In this 
model, Nodal-induced phosphorylation of Smad2 (Dubrulle et al., 2015), recruits 
transcription factors, activating chromatin modifiers, and RNA polymerase to cis-
regulatory elements to promote transcription. Notably, the dCas9-UTX fusion protein 
reduced H3K27me3 marks only when targeted to several sites within the target locus, 
suggesting that this fusion protein acts locally or that synergistic interactions are 
needed to demethylate histone marks in vivo.  
Our study provides the first application of targeted histone modifying 
technologies to a vertebrate embryo. dCas9-effector fusions have been previously 
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used in tissue culture to study the effect of H3K27ac and H3K4me2 levels on 
enhancer activity (Hilton et al., 2015; Kearns et al., 2015). Using targeted recruitment 
of additional histone modifiers, the role of chromatin marks can now be interrogated 
directly, rather than through correlations in mutants. Such tools will be indispensible 
in dissecting the complex relationship between chromatin marks and gene regulation 
during vertebrate development. 
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MATERIALS AND METHODS 
 
Chromatin Immunoprecipitation (ChIP) 
Zebrafish TLAB embryos were dechorionated with pronase at one-cell stage, and 
300-500 embryos at shield stage were used for each treatment, as previously 
described (see Chapter II). Antibodies used were histone H3 (Abcam ab1791), 
H3K4me3 (Millipore 07-473), H3K27me3 (Millipore 07-449).  
 
ChIP-qPCR 
ChIP was done using shield stage embryos. The eluted DNA was analyzed using 
SYBR® Green I (BioRad) and DNA Engine Opticon System (MJ Research) with 
technical duplicates. ChIP enrichment was normalized to input, and shown as 
enrichment relative to an intergenic control region upstream of gene lft2. Statistical 
analysis was performed with the Student’s t test on paired data sets to calculate two-
tailed P values. 
 
ChIP-Seq 
ChIP with H3K4me3 and H3K27me3 antibody was performed as described. Embryos 
were untreated, incubated at 1-cell stage with 10mM Nodal inhibitor drug SB-505124 
(DaCosta Byfield et al., 2004)(S4696 SIGMA), or injected at 1-cell stage with 5pg of 
squint mRNA. Sample DNA was sequenced on Illumina Hi-Seq platform, and aligned 
to Danio rerio genome Zv9 assembly. For the analysis of Nodal responsive chromatin 
marks, peaks were called using MACS2 program (Zhang et al., 2008a) (default 
settings, except q-value = 0.005), comparing the squint injected and drug treated 
samples. To identify regions where H3K4me3 levels increased in response to Nodal 
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signaling, Squint-injected samples were used as tag tracks, and the drug-treated 
samples as the control tracks. The reverse was done to find regions with increased 
levels of H3K27me3 upon Nodal depletion: drug-treated sample was used as the tag 
track, squint-injected sample as the control track.  
 
RNA-Seq  
Sample preparation was done as previously described (see Chapter II). Embryos were 
untreated, incubated at 1-cell stage with 10mM Nodal inhibitor drug SB-505124 
(DaCosta Byfield et al., 2004)(S4696 SIGMA), or injected at 1-cell stage with 5pg of 
squint mRNA. Samples were sequenced on Illumina Hi-Seq platform, and aligned to 
Danio rerio genome Zv9 assembly.  
 
Plasmid constructs 
All dCas9 fusion constructs – dCas9-VP64, dCas9-sfGFP (super-folder GFP 
(Pédelacq et al., 2006)), dCas9-UTX, and dCas9-UTX-H1146A – were cloned into 
the pCS2+ vector using isothermal assembly (Gibson et al., 2009). The sequence of 
UTX was derived from the zebrafish kdm6al gene (previously name utx1) by 
amplifying from shield stage cDNA. The UTX protein was truncated to a catalytic 
jumonji domain that has been crystallized for the human coding sequence (Hong et 
al., 2007), which has 78% identity to the same domain in zebrafish kdm6al. A 20 
amino acid linker was used to connect dCas9 to UTX and sfGFP, while a linker of 
five amino acids was used in dCas9-VP64. The catalytic activity of UTX was 
eliminated by mutating a conserved histidine residue, number 1146 in the human 
UTX protein to alanine in the dCas9-UTX-H1146A construct. All constructs were 
linearized with NotI, and mRNA was transcribed using the mMachine SP6 kit 
! I=!
(Ambion), DNase treated, and precipitated with lithium chloride. RNA concentration 
was quantified using Nanodrop spectrophotometer. 
 
Production and testing of gRNAs 
Templates for gRNA transcription were generated by annealing oligonucleotides 
containing the T7 promoter and a 20 base-pair gene-specific sequence to an 
oligonucleotide encoding the reverse complement of the constant region of the gRNA, 
as previously described (Gagnon et al., 2014). The annealed product was converted to 
a double-stranded template by filling in the ssDNA overhangs with T4 DNA 
polymerase (NEB) and purified with the E.Z.N.A. Cycle-Pure kit (Omega). Differing 
from previous work, a modified constant region was used. As in previous work, the 
bases at the first two positions in the gRNA were always substituted for guanine to 
accommodate preferences of T7 RNA polymerase regardless of the genomic 
sequence. All gRNAs were transcribed with the Megascript T7 kit (Ambion), DNase 
treated, and purified by ammonium acetate/ethanol precipitation. RNA concentration 
was determined using Nanodrop spectrophotometer and agarose gel electrophoresis. 
Activity of gRNAs was tested by T7 Endonuclease I assays on the PCR products 
encompassing the gRNA target site, amplified from HotSHOT-extracted genomic 
DNA (Meeker et al., 2007) from pools of 20 embryos grown to 24-30 hpf following 
microinjection with gRNA and catalytically active Cas9. 
 
Fish husbandry and microinjection 
Zebrafish TLAB embryos were dechorionated with pronase at one-cell stage. The 
embryos were injected with 300 pg of mRNA for each dCas9 construct and an 
approximately equimolar mix of the gRNAs being tested in an excess (Gagnon et al., 
! I>!
2014; Hwang et al., 2013) amount (300-500 pg). For expression studies, embryos 
were injected at 1-cell stage with different amounts of Squint mRNA: 0.1, 0.4, 1.6 or 
4pg.  
 
RT-qPCR 
For gene expression analysis, total RNA was isolated from approximately 20 shield 
stage zebrafish embryos using QIAgene RNeasy kit. cDNA was made from total 
RNA using BioRad iScript kit, and analyzed using SYBR® Green I (BioRad) and 
DNA Engine Opticon System (MJ Research). A housekeeping gene β-actin was used 
for normalization across samples.   
 
In situ hybridization 
In situ hybridization on whole mount embryos was carried out using standard 
methods. Embryos were fixed in 4% formaldehyde overnight, and then dehydrated, 
rehydrated, and stained. Following staining, embryos were cleared in benzyl 
benzoate/benzyl alcohol (2:1 vol/vol) and imaged.  
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CHAPTER V 
Perspectives and outstanding questions  
 
Differential gene expression regulation in response to exposure to different levels 
of Nodal  
One of the most interesting aspects of Nodal signaling is its nature as a 
morphogen. It is the first identified endogenous vertebrate morphogen, and a lot of 
research has been dedicated to understanding how the gradient is formed and 
interpreted (Chen and Schier, 2001; Rogers and Schier, 2011; Schier, 2009). The 
question of how, exactly, high levels of and/or long exposure to Nodal signals can 
activate one group of genes, and low levels/short exposure – another, still remains 
unanswered. A similar question about the mechanism of how Nodal signaling 
switches function exists in the field of human stem cell biology, where this signal can 
both maintain pluripotency and induce differentiation. It has been suggested that this 
is achieved through the existence of ‘synexpression groups’, where Smads regulate 
different groups of target genes in different manners via specific cofactors. It has, 
indeed been observed that different cofactors in stem cells show specificity for either 
pluripotency or differentiation genes (Pauklin and Vallier, 2015).  
Whether the different groups of genes that Nodal activates during 
zebrafish embryogenesis are regulated in this way remains to be seen. Notably, while 
some Smad2-interacting transcription factors are maternally provided (FoxH1, 
EomesA, Oct1), others are expressed later in the development, often in response to 
Nodal signaling (Mixer, Mezzo). The fact that different groups of transcription factors 
appear at different stages supports the idea of synexpression groups in zebrafish, 
especially for groups of genes requiring different lengths of exposure to Nodal. 
! IF!
Proteome-wide analyses are yet to reveal the full list of Smad2 binding partners, and 
we are likely to be underestimating the number of factors that interact with Smad2 
directly or indirectly. Smad2 co-precipitation analyses at different developmental 
stages and in embryos treated with different levels of Nodal will be needed to clarify 
these questions.  
The role of repressive transcription factors in the regulation of Nodal 
target genes has also been possibly underestimated. Negative feedback regulation can 
play important roles in establishing embryonic patterns. For example, I found that the 
binding sites for Zic2/3 and Osr1 transcription factors are very abundant in FoxH1 
and Smad2 binding elements. While it has been observed that Zic2/3 and Osr1 
proteins play a role in dorso-ventral and mesendodermal development in fish and 
other organisms, in depth analysis of how these factors interact with Smad2 has not 
been done (Cast et al., 2012; Grinblat and Sive, 2001; Mudumana et al., 2008; 
Terashima et al., 2014; Winata et al., 2013).  
The molecular function of Smad2 itself is unclear. We do not know 
whether the only role of Smad2 is to assemble the transcriptional complexes required 
for gene activation, or whether it directly controls the activation of epigenetic 
modifiers and transcriptional apparatus.  
 
Function and action mechanism of FoxH1 as a pioneer factor 
The fact that FoxH1 binds to enhancers without Nodal signaling and 
later recruits Smad2 to these loci suggests that FoxH1 plays the role of a pioneer 
factor. There are, however, still tests to be done to confirm that FoxH1 can, indeed, 
bind to DNA independently of other factors. Many, though not all, FoxH1 binding 
sites possess an Oct-family consensus binding sequence. It is possible, therefore, that 
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FoxH1 can only bind to DNA at the positions where Oct4, for example, is already 
bound. To test this possibility, we would need to do FoxH1 pull-down experiments in 
Oct4 mutant background. If FoxH1 is, indeed, a pioneer factor, it should be able to 
bind to some if not all of its binding loci even in these embryos.   
Since previously identified pioneer factors often play roles in 
modifying/remodeling histones and changing/maintaining DNA methylation status, 
we should also be able to observe chromatin mark changes associated with FoxH1 
binding. ChIP-Seq experiments in FoxH1 mutant background, as well as co-
immunoprecipitation experiments to identify potential chromatin modifiers that 
interact with FoxH1, should be able to answer some of these questions,.  
Developmental studies have identified many transcription factors that 
are likely to function as pioneer factors. One such transcription factor MyoD can 
initiate the myogenic program when introduced into many types of terminally 
differentiated cells (Weintraub et al., 1989). It has since been shown that many such 
pioneer factors can initiate reprogramming of cells (Iwafuchi-Doi and Zaret, 2014). 
There is significant interest in using these direct reprogramming approaches to create 
cells of biomedical interest, including mesendoderm-derived tissues, such as liver 
hepatocytes and pancreatic b cells. If FoxH1 does prove to be capable of affecting cell 
reprogramming, possibly in the presence of Nodal signals, this would be and 
important finding for the biomedical field. 
 
The interaction of Nodal signaling and chromatin  
Chapter IV of this work addressed the interaction between Nodal 
signaling and H3K4me3/K27me3 marks on its target genes. While we shed some light 
on what happens to these marks in the presence or absence of this signal, there are 
! II!
still a lot of answered questions. We still do not understand the sequence of events 
that happen at the chromatin level. A number of different scenarios are possible here, 
one where upon zygotic genome activation most of the Nodal target genes acquire a 
bivalent mark, which then resolves either into a silencing or activating one, depending 
on Nodal exposure. It is also possible that many of these genes possess monovalent 
H3K4me3 mark, and then either acquire the silencing modification or not, if Nodal is 
detected. The third possibility is that these genes are not marked at first, and then 
acquire H3K4me3 or H3K27me3, depending on the signaling status. Very few genes 
have been shown to possess the monovalent H3K27me3 mark, so it not likely that 
such is the starting status of the target genes (Vastenhouw et al., 2010).  
While many of the Nodal regulated genes possess both H3K4me3 and 
H3K27me3 mark in wild-type embryos right after zygotic activation, it is not clear 
whether those are truly bivalent marks, or the result of heterogeneity of the cell 
population (Vastenhouw et al., 2010). Sequential ChIP experiments would be required 
to come to a definite conclusion on this matter.  
A large number of chromatin modifications are involved in gene 
regulation, and are certain to also be involved in the Nodal target gene activation and 
repression (Ross and Hill, 2008). We will need to delineate the sequence of events at 
the chromatin level to really understand the roles of different transcription factors in 
expression regulation. Cas9-based tools should be able to help with a lot of these 
studies, as exemplified by our work.  
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Biomedical applications: detangling the dual function of Nodal signaling in stem 
cells  
Nodal signaling controls various mechanisms in different model 
organisms and in a diversity of cell types. In embryonic stem cells it is required for 
self-renewal as well as mesendoderm development. It is difficult to untangle these 
two roles of Nodal in stem cell culture studies, as gain or loss of this signal can lead to 
uncontrolled proliferation or quiescence. On the other hand, studying the role of 
Nodal signaling in the early zebrafish embryo allows us to focus on its role in 
differentiation. Since many cancers are associated with defects in Nodal regulation of 
self-renewal and cell-cycle control, a more complete picture of the mechanistic 
aspects of Nodal signaling in zebrafish could help us separate these functions and 
develop novel therapeutic targets for the treatment of cancer. 
Until a few years ago there was a significant limitation to the types of 
experiments that could be done in zebrafish because many tools for genomic 
manipulation don’t work very well in this system. Targeted mutations for example 
were almost impossible to do. With the discovery of Cas9-based genomic 
manipulations, however, the field changed completely. A new mutant for a specific 
gene can be created in just a few months. Cas9 can also be used for targeted 
recruitment of various factors to DNA, including histone-modifying factors, as we 
demonstrated in chapter IV. Zebrafish embryos are also particularly well suited for 
large-scale screening of therapeutic drugs.  Taken together, these facts indicate that 
studying Nodal signaling in early zebrafish development will continue to be important 
from biomedical standpoint as well as for our basic understanding of biology.  
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